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Abstract 
 
The ataxin-3 gene (ATXN3; 14q32.1) encodes a ubiquitously expressed deubiquitinating 
enzyme, conserved throughout eukaryotes, with homologues among metazoans and found also 
in plants and protozoans. In humans, ATXN3 may expand and encode an abnormally long 
polyglutamine stretch, polyQ, responsible for the most common dominant ataxia worldwide: 
Machado-Joseph disease (MJD/SCA3). The expanded protein gains toxic properties but the 
normal ataxin-3 seems also to influence the disease pathogenesis. ATXN3 has two poorly 
studied paralogues, originated by transposition events: ataxin-3 like (ATXN3L; Xp22.2) and 
LOC100132280 (8q23.2), here named ATXN3L1 and ATXN3L2, respectively. Interestingly, a 
recent in vitro study has shown the ability of ATXN3L1 to cleave ubiquitin substrates, with its 
protease domain significantly more efficient than the ATXN3 domain. Regarding ATXN3L2, in 
silico analyses previously performed in our lab predicted only short reading frames for its 
translation. Still, if transcribed, these short mRNA molecules may have functional relevance by 
regulating the expression of the parental gene, as demonstrated for other transcripts originated 
from retrocopies. 
Our aims were (1) to study the mechanisms that led to the human-specific (CAG)n expansion in 
the parental ATXN3, but not in other lineages or paralogues; (2) to estimate the onset of the 
retrotransposition events; (3) to compare the rates of evolution and selective constraints among 
all three genes in the primate lineage; and (4) to assess the mRNA expression pattern of the 
retrocopy that conserved an intact ORF (ATXN3L1) in human tissues. 
We have found a ATXN3L1 CAG repeat poorly polymorphic and highly interrupted across the 
primate lineage, whereas a pure (CAG)n was observed in ATXN3L2 of most species, with 
humans and chimpanzees showing a polymorphic (CGGCAG)n. Instability encompassing this 
hexanucleotide may have resulted from a CAG to CGG mutation occurred after the Gorilla-Pan 
split, followed by unequal crossover. We have also found evidence of unequal crossover events 
in ATXN3 of orangutan. Phylogenetic results suggested that ATXN3L1 and ATXN3L2 arose by 
two independent retrotransposition events, in Haplorrhini (~63 MYA), and before the Platyrrhini-
Catarrhini split (~43 MYA), respectively. Branch models performed indicated that ATXN3L1 has 
been under selective constraints throughout primate evolution, reinforcing its functional 
relevance, whereas ATXN3L2 gained premature stop codons that likely turned it into a 
processed pseudogene. In fact, we confirmed by Reverse Transcriptase PCR, that ATXN3L1 is 
transcriptionally-active in humans, with mRNA expression in testis, placenta, brain, spleen, and 
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thymus. Further studies will be done to confirm the presence of endogenous protein in vivo and 
to better understand the functional diversification of ATXN3L1. 
 
Keywords: Ataxin-3; Retrotransposition; Paralogue genes; Machado-Joseph disease; Evolution 
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Resumo 
 
O gene ataxin-3 (ATXN3; 14q32.1) codifica uma enzima de expressão ubíqua pertencente ao 
grupo das desubiquitinases. A ataxina-3 é conservada nos eucariotas, com ortólogos descritos 
nos metazoários, em plantas e, também, em protozoários. Em humanos, o gene ATXN3 pode 
apresentar uma região repetitiva expandida que codifica uma proteína poliglutamínica mais 
longa do que o normal. A doença de Machado-Joseph (DMJ/SCA3), considerada a ataxia 
dominante mais comum em todo o mundo, é causada por ganho de função da proteína 
expandida, mas a ataxina-3 normal parece ser um modificador da apresentação clínica da 
doença. O gene ATXN3 tem dois genes parálogos ainda pouco estudados, originados a partir 
de eventos de retrotransposição: ataxin-3 like (ATXN3L; Xp22.2) e LOC100132280 (8q23.2), 
denominados por nós como ATXN3L1 e ATXN3L2, respetivamente. Relativamente a ATXN3L1, 
é interessante referenciar um estudo in vitro realizado recentemente que demonstra a 
capacidade da ATXN3L, através do seu domínio proteolítico, quebrar ligações entre ubiquitinas 
mais eficazmente do que a ataxina-3 parental. Quanto a ATXN3L2, análises in silico já 
realizadas por nós, demonstraram a aquisição de vários codões stop prematuros, o que se 
reflete na existência de open reading frames (ORFs) muito interrompidas. Ainda assim, não se 
pode negligenciar a importância deste parálogo pois, tal como demonstrado para outros 
transcritos orginados a partir de retrocópias, as pequenas moléculas de mRNA podem 
desempenhar funções ao nível da regulação da expressão do gene parental. 
Os nossos objetivos foram (1) o estudo dos mecanismos que levaram à expansão do (CAG)n 
no gene ATXN3 humano; (2) a determinação da origem dos eventos de retrotransposição que 
levaram ao surgimento dos dois parálogos em estudo; (3) a comparação das taxas de evolução 
e das pressões seletivas dos 3 genes em estudo ao longo das diversas linhagens de primatas; 
e (4) a determinação do padrão de expressão do gene ATXN3L1 em tecidos humanos, uma 
vez que se apresenta como o gene mais conservado. 
De acordo com os nossos resultados, o motivo repetitivo CAG do gene ATXN3L1 apresenta-se 
pouco polimórfico e altamente interrompido ao longo das linhagens de primatas, enquanto que 
o gene ATXN3L2 possui um motivo repetitivo puro em quase todas as espécies estudadas, 
excetuando, por exemplo, os humanos e os chimpanzés que apresentam o motivo 
(CGGCAG)n. A instabilidade inerente a este hexanucleotídio poderá ter resultado a partir de 
uma mutação de CAG para CGG logo após a divergência gorila-chimpanzé, seguida de 
recombinação desigual. Análises filogenéticas sugerem dois eventos de retrotransposição 
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distintos na origem de ATXN3L1 e ATXN3L2, ocorridos, respectivamente, há cerca de 63 
milhões de anos nos haplorrínios e 43 milhões de anos antes da divergência platirrínios-
catarrínios. Os valores de omega (ω) calculados para ATXN3L1 indicam que se trata de um 
gene sob pressões seletivas purificadoras, sugerindo, assim, tratar-se de um retrogene com 
relevância funcional. O RT-PCR (reverse transcriptase) realizado por nós confirma isso mesmo, 
mostrando que o gene ATXN3L1 é transcrito pelo menos em testículo, placenta, cérebro, baço 
e timo. Subsequentemente, terão de ser elaborados mais estudos para confirmar a presença 
da proteína in vivo e perceber melhor a função desta proteína.  
 
Palavras-chave: Ataxina-3; Retrotransposição; Genes parálogos; Doença de Machado-Joseph; 
Evolução 
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1. Origin of new genes 
The emergence of new genes is fundamental to the evolution of species-specific traits [1]. The 
major mechanism providing raw material for the origin of new genes is gene duplication. There 
are two types of gene duplication: direct duplication of genomic DNA and retropositional events 
[2]. In the first case, gene copies present often the same exon-intron organization and similar 
expression patterns when compared to parental genes: duplication of chromosomal segments 
[1]. Gene duplicates may, however, lose their core promoters and their protein-coding potential 
if tandem duplication or uneven crossing-over is in their origin [3]. In the case of 
retrotransposition, re-integration of reverse transcribed mRNA molecules occurs in the genome 
[4]. This is the mechanism by which our genes of interest have arisen, and for this reason, in 
next topics, we will explain it in more detail. 
 
1.1 Retrotransposition events 
Transposable elements have contributed greatly to what we now realize to be a highly dynamic 
genome. An example are the retrotransposons which encode a reverse transcriptase (RT) 
activity and move by a “copy and paste” process involving an RNA intermediate [5].  
 
 
 
 
 
 
 
 
 
 
 
 
 
L1 elements are autonomous non-LTR (Long Terminal Repeat) retrotransposons classified as 
LINEs (Long Interspersed Nucleotide Elements) and are widely present in mammalian genomes 
(about 25% of their genome), being  responsible for a burst on the number of retrocopies in 
R
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LTR (Long Terminal 
Repeat)  
LINES (Long Interspersed 
Nucleotide Elements) 
Non-autonomous 
SINES (Short Interspersed 
Nucleotide Elements)  
Figure 1: Classification of the different types of retrotransposons. 
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mammalian lineages [4]. Besides duplicating themselves, L1 elements likely have been 
responsible for the genomic expansion of the non-autonomous retrotransposons SINES (Short 
Interspersed Nucleotide Elements) since they do not encode any proteins and nor possess an 
independent mobility. Among SINEs, we can find Alu elements, processed pseudogenes, and 
other elements in the human genome [5]. 
 
A. 
 
 
 
 
 
B. 
 
 
 
 
Figure 2: Structure of mammalian transposable elements. A. L1 consists of a 5’ untranslated region (5’UTR), two ORFs (Open 
Reading Frames) separated by a short intergenic region, a 3’UTR, a polyA signal (AATAAA), and a polyA tail (A(n)). L1 elements are 
often flanked by 7–20 bp target site duplications (TSD). In ORF2, both RT (reverse transcriptase) and EN (endonuclease) domains, 
as well as a conserved cysteine-rich motif (C) are annotated; B. Alu elements contain two similar sequences, the left (L) and right 
monomers (R) and end in a polyA tail. (Adapted from Ostertag, 2001) [5].  
 
  
 
Retrocopies lack many of the genetic features of their parental genes, such as introns and 
regulatory elements [6]; for a long time, this has contributed to the idea that only non-functional 
duplicate gene copies could result from gene retrotransposition. Subsequent analyses 
suggested, however, that retroposition had efficiently sown the seeds of evolution in genomes 
[7]; and more recent genome-wide searches of retroposed genes have confirmed the 
importance of gene retrotransposition in the origin of new functional genes in fly and primates 
[8-14]. In humans, although selection generally acted against the insertion and high transcription 
of retrocopies located inside other genes, it favored the emergence of a substantial number of 
new genes with diverse gene structures and functions [1]. 
Retrogenes have for long time been described as pseudogenes, however, since raising 
evidence of retrocopies functionality, the term retrogene has now been widely used to describe 
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functional retrocopied genes. On the other hand, pseudogenes consist in genomic DNA 
sequences lacking the protein-coding capability of their paralogous counterpart because of 
frameshifts or premature stop codons [15]. Thus, the term “pseudogene” implies non-
functionality, frequently viewed as a molecular fossil and used to measure background genomic 
substitution rates [16, 17].  
Retrogenes may directly inherit promoters from their parental transcripts as has been observed 
for individual cases [18], but they often use the regulatory elements of host genes that surround 
the insertion site (suggesting that retrocopy transcription is frequently driven by the machinery of 
nearby genes). In fact, regions surrounding retrogenes are transcriptionally more active than 
regions flanking silent retrocopies. New retrogenes may also emerge from truncated regions 
coding small RNAs that may regulate other genes expression [1].  
The transcription of a retrogene is not, however, sufficient evidence of biological function.  
Additional confirmation of the functionality of these retrocopies is their ancient origin and strong 
conservation throughout evolution [15]. The analysis of conserved retrogenes has shown that 
50% are indeed conserved across millions of years of primate evolution (far fewer are though to 
be conserved between species more distant to human, such as rodents) [3]. 
 
1.1.1 Retrotransposons as genetic markers 
As revealed by pioneering studies on humans, primates and other non-primate groups, 
retrotransposons afford several advantages that make them very powerful tools as genetic 
markers for studying human and non-human primate evolutionary histories [19-22].  
When compared to retrotransposons, the most often used genetic markers (such as single 
nucleotide polymorphisms (SNPs), restriction site polymorphisms (RSPs) and short tandem 
repeats (STRs)) suffer from higher probabilities of homoplasy and greater difficulty of confidently 
establishing the ancestral marker state. On the other hand, LINE and SINE insertions have two 
uniquely valuable properties as markers for phylogenetic and population genetic analyses: first, 
they are virtually free of homoplasy since every observed insertion of the same element 
sequence is identical by descent; second, the ancestral state of the locus is known to be the 
absence of the insertion [23].  
Retrotransposon insertion polymorphisms have also being used as forensic tools, for example, 
in species specific DNA detection and quantitation, analysis of complex biomaterials, human 
gender determination and inference of geographic origin of human samples [24]. 
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2. ATXN3 paralogues 
Ataxin-3 (ATXN3; 14q32.2) was described as containing 11 exons, resulting in at least four 
different mRNAs due to alternative splicing. More recently, two additional exons (6a and 9a) and 
56 alternative transcripts have been described [25, 26]. The (CAG)n tract, located in exon 10, 
displays usually the (CAG)2 CAA AAG CAG CAA (CAG)n configuration [27]. In most transcripts, 
including the widely frequent ATXN3-001, this repeat is in the 5’ part of the exon, with a single 
adenine nucleotide before the reiteration site, at the beginning of the exonic region [28].  
Orthologues and paralogues are types of homologous genes that are related by speciation or 
duplication, respectively [29, 30]. The ATXN3 gene has two paralogues in the genome of 
several primates. Both ataxin-3 like (Xp22.2) and LOC100132280 (8q23.2) (here named ataxin-
3 like 1, ATXN3L1; and ataxin-3 like 2, ATXN3L2, respectively) are intronless copies of ATXN3, 
which hint retrotransposition for their origin. In humans, ATXN3 and ATXN3L1 share 85% 
sequence identity in their catalytic Josephin domains and high similar crystal structures [31]. 
 
A. B. 
 
 
 
 
 
 
Figure 3: Comparison of the ATXN3 and ATXN3L1 structures. A. Schematic representation of ATXN3 and ATXN3L1 proteins. 
Josephin domains are shown in light gray, the UIMs are shown in dark gray, and the polyglutamine (polyQ) repeat regions are 
shown as cross-hatched. The sizes of the UIMs and polyQ regions are not shown to scale. The scale at top shows length in amino 
acids; B. Superposition of the ATXN3L1 crystal structure (blue) and free ATXN3 solution structure. (Adapted from Weeks et al., 
2011) [31]. 
 
 
The other ATXN3 paralogue, ATXN3L2 shares about 70% homology with the parental gene, in 
humans. This homologous region presents an interrupted ORF, suggesting that this is a 
processed pseudogene of ATXN3 [32]. 
Regarding that the two human copies of ATXN3 described above remain poorly studied, it is of 
great importance to better characterize these retrocopies and to further explore, in the case of 
ATXN3L1, its potential role in the pathogenesis of Machado-Joseph Disease. 
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3. J D proteins 
Josephin Domain (JD) containing proteins are the smallest family of deubiquitinating enzymes 
(DUBs), all sharing a highly conserved JD catalytic domain. They are found in a wide range of 
phylogenetic groups, including protists, plants, and metazoans. The term MJD class has also 
been used after the identification of the neurodegenerative Machado-Joseph disease (MJD), 
caused by the best-studied protein of this class, ATXN3. This protein family comprises two 
defined subgroups named ataxins and Josephins, based on the sequence homology of their JD. 
In almost all species, Josephins (JOSD1 and JOSD2) consist of JD alone, while ataxins (ATXN3 
and ATXN3L1) contain an additional C-terminus with two or three ubiquitin interaction motifs 
(UIMs) and a polyQ tract [33].  
Little is known about ATXN3L, JOSD1 and JOSD2, and only very recent studies have provided 
some insights into their characterization [31, 34]. 
 
3.1 Ataxin-3  
Ataxin-3 is the best-characterized JD protein [26]. It presents an approximate molecular weight 
of 40-43 kDa in normal individuals and structurally is composed by a globular N-terminal 
Josephin domain with a papain-like fold, combined with an unstructured C-terminus that 
contains two or three UIMs and the polymorphic polyQ tract [33]. The catalytic pocket consists 
of a glutamine (Q9) and a cysteine (C14) residue located in the N-terminal part of the JD, and a 
histidine (H119) and an asparagine (N134) in the JD C-terminal part [26]. When ATXN3 is not 
bound to other cellular components, its structure is much less compact than when interacting 
with other cellular partners, which stabilizes the fold of the C-terminus [35]. The N-terminal 
domain and the catalytic cysteine residue consist mainly of alpha helices, while the catalytic 
histidine and the orienting glutamine residue are found in a beta-strand context [36]. 
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Figure 4: Domain architecture, structure and post-translation modifications of ATXN3. ATXN3 is mainly composed of a globular N-
terminal catalytic domain, the JD, with DUB activity, followed by a flexible C-terminal tail containing 2 or 3 UIMS (depending on the 
alternative transcripts) and a polyQ sequence of variable length. Five serine residues (S236, S256, S260/S261, S340, S352) have 
been identified in the UIMs as phosphorylation sites, and a ubiquitinatable lysine residue was mapped to aminoacid 117, in the JD. 
One functional nuclear localization signal (NLS) was described in the region linking the second UIM to the polyQ region and two 
nuclear export signals (NES) were reported in the JD. Rad23 and VCP/p97, the two most frequently described interacting partners 
of ATXN3, bind to the JD and the C-terminal region of the protein, respectively [37]. 
 
 
 
3.1.1 Function 
It has been suggested that the wild-type ATXN3 protein could act mainly as a deubiquitinating 
enzyme in the ubiquitin-proteasome pathway (UPP) [38]. DUBs, as well as other regulators of 
the UPP, have been linked to neurodegenerative diseases that are characterized by protein 
misfolding and aggregation [31]. Ubiquitin (Ub) is an 8-kDa protein covalently attached to lysine 
residues in specific substrates. It is implicated in diverse cellular processes and pathways 
including transcription, protein degradation, cell cycle progression, viral infection, and immune 
response [39, 40]. Once attached, ubiquitin can be removed by DUB enzymes, proteases that 
specifically remove adducts from the C-termini of ubiquitin molecules [31].  
The catalytic activity of ATXN3 affects besides its own protein levels and ubiquitination pattern, 
its subcellular localization [41]. ATXN3 is ubiquitously expressed, existing in the nucleus and 
predominantly in cytoplasm of various cell types [42]. Nuclear export of ataxin-3 is dependent on 
a complex ATXN3 motif, located in the N-terminal portion of the protein, which requires the 
Josephin domain plus the ubiquitin-interacting motifs [41]. 
Many cell models have suggested a role for ATXN3 in transcriptional repression via inhibition of 
histone acetyltransferase (HAT) activity of the major transcriptional coactivators, cAMP 
response, element-binding protein (CREB), CREB binding protein (CBP), p300, and p300/CBP-
associated factor (PCAF) [43, 44]. In addition, Evert et al. (2006) have shown that ATXN3 binds 
to specific sites in chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter 
and interacts with the transcriptional corepressors HDAC3 and NCoR, resulting in deacetylation 
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of histones and reduced binding of the transcription factor GATA-2 to target regions of the 
MMP-2 promoter [44]. 
Some other functions have been suggested for ataxin-3 as its importance for a correct 
cytoskeletal organization and muscle differentiation through the regulation of the integrin 
signaling transduction pathway [26]. More recently, Zhou et al. (2013) showed ataxin-3 to act as 
a novel anti-oxidative regulator in cooperation with mitochondrial Bcj-2 family proteins under 
oxidative stress conditions [45]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: ATXN3 activity, interactions and proposed biological roles. ATXN3 displays DUB activity (A) and has been shown to 
interact with polyUb chains (B), two features that suggest its involvement in protein homeostasis systems using Ub signals, such as 
the UPP. ATXN3 was also shown to interact with Rad23 and VCP/p27 and to participate in a protein homeostasis mechanism in 
which these proteins are involved – the ERAD (C). ATXN3 has been further linked to aggresome formation (D), through interaction 
with cytoskeleton proteins (tubulin and dynein), and to the organization of the cytoskeleton itself (E). Interactions with regulators of 
histone acetylation support many reports describing ATXN3 as a participant in transcription regulation (F) [37]. 
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3.2 ATXN3L 
Studies focusing on the modulation of parental genes by the respective expressed paralogues 
may be important to gain insight into the mechanisms by which ATXN3 retrocopies (especially 
ATXN3L1) may be functional relevant.  
The gene responsible for spinocerebellar ataxia type 1 (SCA1), ATXN1, has an evolutionary 
conserved paralogue called ATXN1-like. Recent studies in fly and mouse models have shown 
that the overexpression of ATXN1L partially suppresses the neuropathology caused by the 
polyglutamine-expanded ATXN1, by inducing sequestration of polyglutamine-expanded ATXN1 
into nuclear inclusions [46, 47]. They also propose that a combination of toxic gain-of-function 
and mild loss-of-function mechanisms contribute to SCA1 pathogenesis, with the partial loss-of-
function of ATXN1 being sufficient to cause some transcriptional changes that are pathogenic in 
the cerebellum. Also, it has been previously reported that reduction of normal functions of genes 
involved in other polyglutamine diseases results in enhanced pathology, providing evidence for 
concomitant gain- and loss-of function mechanisms in polyglutamine disorders [48-52]. This 
raises the hypothesis that some conserved paralogue genes may compensate a partial loss of 
function of their parental genes. 
Regarding our gene of interest ATXN3L1, it has been shown in an in vitro study that its JD 
presents higher DUB activity than the parental ATXN3 JD [31]. This led the authors to suggest 
that evolution has selectively maintained the ataxin-3 sequence in a less active state (and 
possibly maintained ATXN3L1 in a more active state). Although the crystal structure of the 
ATXN3L1 JD is highly similar to solution structures of the ATXN3 JD, the ubiquitin substrate 
appears to bind at different positions in the two proteins, suggesting a possible explanation for 
the difference between their efficiency. Nevertheless, three single-site mutations into the ATXN3 
JD are sufficient to increase its DUB activity near ATXN3L1 levels [31]. 
 
3.3 Josephins 
Josephin domain containing proteins 1 and 2 (JOSD1 and JOSD2) are thus named once they 
contain only the catalytic josephin domain. Despite their structural similarity, JOSD1 and JOSD2 
differ with respect to base-line catalytic activity, modification by ubiquitin, and subcellular 
localization. JOSD1 is regulated by ubiquitination, suggesting that ubiquitination-dependent 
regulation may be a more common regulatory mechanism for DUBs than previously anticipated. 
At the subcellular level, JOSD1 appears most concentrated at the plasma membrane, especially 
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when ubiquitinated, where it influences membrane dynamics, cell motility and endocytosis. In 
alternative, JOSD2 is diffusely localized in the cytosol [34]. 
 
4. Polyglutamine diseases 
The discovery of human genetic disorders caused by repeat expansions has brought a new 
interest regarding the evolutionary processes that underlie these repeat tracts [53]. 
Polyglutamine (polyQ) diseases constitute a group of hereditary neurodegenerative disorders 
caused by the expansion of a (CAG)n above a certain threshold encoding a protein with several 
consecutive glutamines [37]. There are nine dominantly inherited neurodegenerative disorders 
caused by expanded polyQ tracts: Huntington’s disease (HD), spinal and bulbar muscular 
atrophy (SBMA), dentatorubropallidoluysian atrophy (DRPLA), and six spinocerebellar ataxias 
(SCA1–3, 6, 7 and 17) [54-60]. To date, around 30 types of SCAs are known and 16 genes 
have been identified. Ataxia, borrowed from a Greek word meaning “loss of order,” is used 
clinically to describe aberrant regulation of limb movements with poor coordination between 
limbs. Spinocerebellar ataxia is caused by anomalous function of the spinocerebellum, the part 
of the cerebellar cortex that receives somatosensory input from the spinal cord [61].  
All these diseases are characterized by a selective neuronal loss [37]. Pathogenic polyQ 
proteins can poison the axonal transport system and induce nuclear accumulation of inclusions 
leading to apoptosis [62]. Chaperones may act in order to suppress neurodegeneration by 
channeling toxic protein into nontoxic aggregates [63] but not always in the proper time that 
allows the normal development to proceed [62]. Several genetic studies have revealed that loss 
of the involved proteins in humans and mice does not cause neurodegeneration, leading to the 
conclusion that the polyglutamine expanded protein causes disease by a dominant gain-of-
function mechanism whereby it confers toxic properties to the host proteins [64-70]. However, 
the severe gain-of-function effects might mask any subtle loss-of-function component, thus 
confounding the interpretation of the results. In fact, loss of normal endogenous function of 
mutant proteins may also play a role in dominant neurodegenerative diseases caused by gain-
of-function mutations [71].  
Several polyglutamine disease proteins repress transcription; therefore, characterization of the 
mechanisms of transcriptional repression is critical for understanding cellular pathology as well 
as for identifying potential targets for therapeutic intervention [72].  
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5. Machado-Joseph disease 
Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is one of 
the late-onset autosomal dominant spinocerebellar ataxias [73]. The gene associated with this 
disease is ATXN3, which was mapped to the long arm of chromosome 14 (14q24.3–q32) [74]. 
The causative mutation is an expansion of a CAG repeat located in the coding region of ATXN3. 
Healthy individuals have triplets ranging from 12 to 44 units whereas patients present usually 
one allele with 61 to 87 repeats [25]. Intermediate size alleles are rare and their pathogenicity 
still unclear [26]. 
MJD was first described in Azorean-Portuguese families living in the United States but, 
meanwhile, many patients from different ethnic backgrounds have been reported and MJD 
appears currently to be the most common SCA worldwide. The highest frequencies have been 
reported in Brazil (69-92%) [75], Portugal (58-74%) [76], Singapore (53%) [77], China (48-49%) 
[78], the Netherlands (44%) [79], Germany (42%) [80], and Japan (28-63%) [81], followed by 
Canada (24%) [82], United States (21%) [83], Mexico (12%) [84], Australia (12%) [85], and India 
(5-14%) [86], whereas it is considered as relatively rare in South Africa (4%) [87] and Italy (1%) 
[88]. MJD is highly pleomorphic in its clinical presentation, which led to the definition of the 
following 3 subphenotypes: type 1, the most severe form, is characterized by an earlier onset 
(mean age: 24.3 years), marked spasticity, dystonic features, cerebellar ataxia and 
ophthalmoplegia; type 2, the most common, is characterized by onset in midadulthood (mean 
age: 40.5 years), cerebellar ataxia, ophthalmoplegia, and pyramidal signs; type 3, 
corresponding to the mildest form, is characterized by a later onset (mean age: 46.8 years ) and 
marked peripheral amyotrophies in addition to the main signs [89]. 
At the clinical level, there is a strong and consistent inverse correlation between the age at 
onset and the length of the expansion - the bigger the repeat the earlier symptoms appear in life 
[90]. Expansion size, however, is not the only variant that influences age at onset. The protein 
context, cis-acting genetic factors (typically familial or ethnic) in linkage disequilibrium with the 
affected alleles, trans-acting genetic factors, the tissue context in which the cognate protein is 
expressed, and environmental factors seem also to influence SCAs age at onset [79]. In MJD, 
repeat expansions are more common than contractions [90], leading to anticipation, a clinical 
phenomenon characterized by an earlier onset and increased disease severity in successive 
generations [91]. Expanded alleles are very unstable upon transmission and increase in the size 
of the expanded alleles tends to be greater when the transmitting parent is the father [92-94]. 
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Homozygosity is also a condition that clearly enhances the severity of the clinical phenotype 
impairment, which supports a partial loss-of-function in the pathogenesis of the disease [90]. 
In MJD patients, the ATXN3 gene is widely expressed in the brain and other organs in both 
normal and pathogenic forms [90]. It has been suggested that the catalytically inactive form of 
expanded ATXN3 may accumulate more readily in neurons and therefore induce more 
neurotoxic [95]. The nuclear localization of ataxin-3 aggravates the formation of protein 
aggregates and the development of a phenotype, whereas nuclear export of the protein results 
in a reduced number of nuclear inclusions (NIIs) and a much milder phenotype. Therefore, 
keeping the expanded polyglutamine repeats in the cytoplasm might delay protein aggregation, 
giving easier and longer access of the toxic protein to the protein degradation machinery [96]. 
Live-cell imaging studies showed that expanded polyQ tracts slow the dynamics of intact ataxin-
3, and that the export of expanded protein is less efficient than the export of normal ataxin-3, 
suggesting a defect on the nucleocytoplasmic shuttling activity of the expanded protein [41]. 
It is commonly believed that neuronal damage in MJD is due to a gain of function mechanism 
characterized by misfolding, aggregation and subsequent formation of amyloid fibers by the 
polyQ-containing proteins or their fragments [97]. ATXN3 UIM domain binds polyubiquitylated 
proteins with a strong preference for chains containing four or more ubiquitins, which is the 
chain length required for proteasome degradation, cleaving these polyubiquitin chains via its N-
terminal Josephin domain [95, 98]. The expansion of the polyglutamine tract in ataxin-3 makes 
the protein highly susceptible to misfolding and subsequent aggregation, forming intraneuronal, 
ubiquitin-positive inclusions. In addition to the ubiquitylated mutant or misfolded protein, 
aggregates in disease brains recruit normal proteins, including chaperones, and proteasomes, 
creating larger aggregates rather than being degraded by the last ones [39, 98]. Over the 
course of decades this could result in inadequate degradation of many cellular regulators 
resulting in cellular dysfunction [98]. 
Expanded ATXN3 showed also altered DNA and chromatin binding, failed to accomplish 
functional repressor complexes on the promoter, and aberrantly activated MMP-2 expression 
via increased histone acetylation and GATA-2 binding. Normal and expanded ATXN3 have 
been observed to interact with endogenous HDAC3 and NCoR in cell and human brain extracts, 
but only normal ATXN3 was associated with increased deacetylase activities and deacetylation 
of histone H3 [44]. Expanded ATXN3 not only loses its repressing function but acquires also a 
new transcriptional activator function. The new transcriptional activator function is mediated via 
its active site, which probably disturbs the formation or maintenance of histonedeacetylating 
repressor complexes on target promoters. Both the loss of repressor and gain of an activator 
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function result in increased histone acetylation of specific target gene promoters, probably 
leading to altered gene expression in MJD [99, 100]. This repressor activity is dependent on its 
ubiquitin interaction motifs, suggesting a link between ATXN3 function in the 
ubiquitin/proteasome pathway and its role in transcriptional regulation [61]. 
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Given the ongoing evidence of retrogenes functionality, we considered of great importance to 
characterize ATXN3 retrocopies, since in addition to the interest in the biological processes on 
their origin, they may play a role in the pathogenesis of MJD. Therefore, our main objectives 
were: 
 to address the mechanisms that have led to the human-specific ATXN3 (CAG)n 
expansion (not observed in other lineages or paralogues); 
 to determine at which point in primate evolution have the retrotransposition events 
occurred; 
 to compare the rates of evolution and selective constraints among ATXN3 and ATXN3L1 
in the primate lineage; 
 to assess the mRNA expression pattern of the retrocopy that conserves an intact ORF 
(ATXN3L1) in human tissues. 
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1. DNA samples 
We amplified and sequenced DNA samples from 10 non-human primate species: Pan 
troglodytes (n=1), Gorilla gorilla (n=1), Pygmaeus pongus (n=1), Hylobates (n=1), Macaca 
mulatta (n=3), Macaca fuscata (n=15), Macaca fascicularis (n=1), Cercopithecus aethiops (n=1), 
Aotus trivirgatus (n=1), and Saguinus oedipus (n=1). Sequences obtained from these samples 
were analyzed together with others previously assessed by us [32] and with additional ones 
retrieved from public databases as summarized in tables 1 and 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Sequences retrieved from public databases. 
Species 
ATXN3 ATXN3L1 ATXN3L2 
Database Accession/Gene ID Database Accession Database Accession 
H. sapiens Ensembl ENSG00000066427 Ensembl ENSG00000123594 NCBI 100132280 
P. troglodytes Ensembl ENSPTRG00000006648 Ensembl ENSPTRG00000028316 UCSC chr8: 109011629-109012743 
P. paniscus NCBI 100976906 NCBI 100987250 NA NA 
G. gorilla Ensembl ENSGGOG00000014166 NCBI 101124367 UCSC chr8: 109925669-109926225 
P. abelii Ensembl ENSPPYG00000006075 Ensembl ENSPPYG00000020129 UCSC chr8: 117579303-117579866 
N. leucogenys Ensembl ENSNLEG00000017126 Ensembl ENSNLEG00000018731 UCSC GL397267: 24598565-24599123 
P. anubis UCSC chr7: 3062 UCSC chrX: 10617308-10618372 UCSC chr8: 105521214-105522300 
P. hamadryas NA NA UCSC scaffold3734:61188-61980 NA NA 
M. mulatta Ensembl ENSMMUG00000020751 Ensembl ENSMMUG00000009370 UCSC chr8: 112963801-112964361 
S. boliviensis NCBI 101043060 NCBI 101036136 UCSC Genomic JH378207 
C. jacchus Ensembl ENSCJAG00000018025 Ensembl ENSCJAG00000023329 UCSC chr19: 6218140-6218664 
T. syrichta Ensembl ENSTSYG00000009902 Ensembl ENSTSYG00000003386 NA NA 
O. garnettii Ensembl ENSOGAG00000008601 NA NA NA NA 
NA: not available 
Species N 
Pan troglodytes 3 
Gorilla gorilla  4 
Pongo abelii 2 
Pygmaeus pongus 1 
Hylobates 1 
Papio anubis 3 
Macaca mulatta 7 
Macaca fuscata 15 
Macaca fascicularis 4 
Cercopithecus aethiops 1 
Aotus trivirgatus 1 
Callithrix jacchus 3 
Saguinus oedipus 1 
Table 1: Non-human primate 
species sequenced in our lab. 
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2. Whole genome DNA amplification 
In order to have enough amount of DNA to complete our study, all species sequenced in this 
work, excluding Macaca mulatta, were submitted to a random amplification with GenomiPhi V2 
amplification kit (GE Healthcare). Following the instructions provided by the manufacturer, 1 μL 
of DNA was mixed with 9 μL of sample buffer and denatured for 3 min at 95ºC; then, 1 μL of 
enzyme mix was added to 9 μL of the denatured product and incubated at 30ºC for 90 min; and, 
finally, to inactivate the enzyme, the amplified product was heated at 65ºC for 10 min.  
 
3. Amplification of ATXN3L1 and ATXN3L2 
We started by amplifying the genes of interest, ATXN3L1 and ATXN3L2, with primers and 
conditions previously optimized in our lab. Based on the alignment of gene orthologues, primers 
were designed to specifically amplify ATXN3L1 and ATXN3L2 in most primate species [32]. 
In cases when the available protocol did not work properly, we optimized new conditions. Both 
previous and newly optimized protocols were carried out in singleplex PCR reactions using 1 μL 
of genomic DNA, 5 μL of My Taq™ HS MIX (Bioline, London, United Kingdom), 1 μL of each 
primer (with a final concentration of 2.5 μM), and 2 μL of H2O in a final volume of 10 μL. The 
reactions were done in 2720 Thermal Cycler (Applied Biosystems) or Thermal Cycler (BioRad). 
The summary of amplification parameters is described in figure 7 and table 4. 
 
        Table 3: Primers designed to specifically amplify ATXN3L1 and ATXN3L2 genes. 
  ATXN3L1 ATXN3L2 
 
Primer Sequence Primer Sequence 
F
o
rw
a
rd
 
L1F1 CTCTAACTAGGATACCAGCAAAG L2F1 CATTAACCAAAGAAAGTGGGATAC 
L1F2 GTTTCCTGTGTGCTCAGCACTG L2F1s GTAGGAAAATAAACACAGTGAAAC 
L1F3 GAAACCAATAGAGAAGATGAA L2F2 CCAGAGTATCAAAGGCTCAGGATC 
L1F4 AAGATGAGGAGGATTTTCAGAGG L2F3 AGGCTCGCTTTGTGCTCAGCATTG 
    L2F4P7b GAAGAAATCTCTGGAGGGCAG 
    L2P4A GATAAGATAATTTATATGCGA 
    L2P4G GATAAGATAATTTATATGCGG 
R
e
v
e
rs
e
 
L1R1 GGAAAAAGTTCTATGGCAAGAGC L2R1 GGAATCCTATGCTGTAATCACAC 
L1R2 ACTGGTGACTCCTCCTTCTGCCA L2R1s TCACAGCTGCCTGAAAAGTGG  
L1R3 GTCTAAAAGCCTTATTTCCTCATCT L2R2 GTGGTCAGCCTTTCACATGGATA 
L1R4P7 CCTKGCATGCTTAACTCAATAG L2R3 TCTATTACCCAGAGTGGAGTGCAG 
    L2R4 TGGTCTCGAACTCCTGGCCTCA 
    L2R5 CTAAAACTCCTCCTTCTGCC 
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Primers L2F1s and L2R1s were specifically designed taking into account Saguinus oedipus 
sequence obtained in the lab. Similarly, L1R4P7 and L2F4P7b are specific primers to Aotus 
trivirgatus and L2P4A and L2P4G are allele-specific primers to assess the phase of Gorilla 
gorilla ATXN3L2 sequences. 
The following figures help to visualize the annealing site of the primers within our genes. 
A. 
 
B. 
 
Figure 6: Schematic representation of A. ATXN3L1; and B. ATXN3L2 genes, with distances (bp) between selected primers. Start 
and stop codons for ATXN3L1 and the aligned homologous codons for ATXN3L2 are also represented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hold 1 Hold 3 Hold 2 
zx 
15’ 30’’ 
1’30’’ 
95ºC 94ºC 
wºC 
y’ 10’ 
70ºC 72ºC 
Figure 7: General PCR protocol with length of time (‘- minutes; ‘’ 
– seconds) and temperatures (°C) for the amplification ATXN3L1 
and ATXN3L2 loci. x (annealing temperature) – 59 for ATXN3L1; 
and 57 for ATXN3L2; y (extension time) – 2 for ATXN3L1, and 1 
for ATXN3L2; z (number of cycles) - 40 for ATXN3L1; and 35 for 
ATXN3L2. 
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4. Amplification of the parental ATXN3 
For species in which ATXN3 sequences retrieved from databases were incomplete or poorly 
annotated, we used primers previously designed by MI Martins (2012) [32] to specifically amplify 
the parental gene.   
 
 
 
 
  
 
 
 
 
                                                                                                             *nF2 was used in sequencing 
 Species Primers wºC zx 
A
T
X
N
3
L
1
 
Cercopithecus aethiops 
L1F1-L1R1 59 40 
Macaca fascicularis 
Gorilla gorila 
Hylobates 
Pan troglodytes L1F1-L1R3 Touchdown 58-56 20-20 
Pygmaeus pongus L1F1-L1R3 58 40 
Aotus trivirgatus 
L1F1-L1R4P7 58 
40 
L1F2-L1R1 62 
Saguinus oedipus L1F1-L1R1 54 40 
A
T
X
N
3
L
2
 
Cercopithecus aethiops 
L2F1-L2R1 57 35 
Macaca fascicularis 
Gorilla gorilla 
Hylobates 
Pygmaeus pongus 
Saguinus oedipus 
Pan troglodytes L2F1-L2R1 Touchdown 58-56 10-30 
Aotus trivirgatus 
L2F1s-L2R1s 60 
35 L2F3-L2R2 59 
L2F4-L2R1 62 
Sample w y z Primers 
Gorilla gorilla 
60 35 1' F2'-R3 
62 40 2' F3-R3' 
Pongo abelii 58 40 2' F2'-R3 
Macaca mulatta 61 35 2' F1-R1 
Papio anubis 61 35 1' F18-R20 
Primer Sequence 
F1 CGTGTCCCCGGCGTTCACTC 
R1 AGTCGCCCCCATGCCGATCT 
F2' GTGGTAAGCTGAGATTGCTCC 
nF2* ATTATTTAGGGGAGCCGGGCG 
F3 GCAAGAAGGCTCACTTTGTGCTC 
R3 CCAGCTGATGTGCAATTGAGG 
R3' TTTCCCCACCCCCACCCTTG 
F18 CCACTCCTGGCCATGATAGGT 
R20 GGTAAGGCCTGCTCACCATTC 
Table 4: Summary of the PCR conditions and set of primers used to amplify our 
samples. w: annealing temperature; z:  number of cycles. 
 
Table 5: Summary of the PCR conditions 
and set of primers used to amplify our 
samples. w: annealing temperature (ºC); y: 
number of cycles; z: extension time 
(minutes) 
Table 6: Primers designed to specifically amplify 
the ATXN3 gene. 
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5. Detection of amplified products  
To confirm specificity of DNA amplification, PCR products were submitted to electrophoresis in 
a polyacrylamide gel prepared with 0.375 M Tris/HCl gel buffer (pH=8.8). The gel was obtained 
by mixing 3 mL T9C5 (9% acrylamide, 5% N-N-metileno-bis-acrylamide), 170 μL of 2.5 % 
ammonium persulfate (APS) and 7 μL of TEMED as catalysis agent. Glass supports, with one 
side covered by a hydrophilic gel-bond film, were used to obtain a 3 mm thick gel. After loading 
the samples in the gel, two paper strips soaked in buffer were used at both anode and cathode 
to allow the horizontal run. To monitor the process of electrophoresis, we added bromophenol 
blue dye to the anode strip. The electrophoretic system was submitted to refrigeration at 4°C, 
and to a voltage between 220 and 250 V. The gel was then submitted to silver staining. The 
coloration method comprised (1) a fixation step of the DNA, with 10% ethanol for 10 minutes 
followed by 1% nitric acid for 5 minutes; (2) two washes with deionized water, of about 20 
seconds each; (3) a coloration step with 0.2% silver nitrate solution, for 20 minutes; (4) two 
washes again with deionized water, for 20 seconds each; and finally, (5) a revelation step of the 
DNA fragments with a solution of 0.28 M sodium carbonate and 0.02% formaldehyde. The 
revelation reaction was stopped with 10% acetic acid for approximately 30 seconds. The 
resulting gels were washed with water and dried at room temperature. 
 
6. Sequencing 
After confirming specific amplification, an initial purification with ExoFastAP (E. coli exonuclease 
I and thermosensitive Alkaline Phosphatase, Thermo Scientific, Portugal) was performed to 
eliminate the remaining dNTPs and primers that have not been consumed in the amplification 
reaction. In this step, 1.8 μL of PCR product and 0.9 μL of ExoFastAP were used. The 
thermocycler program performed was 15 minutes at 37°C, followed by 15 minutes at 80°C to 
inactivate the enzyme. The sequencing reaction was performed in a total volume of 5 μL, 
including 0.5 μL of primer (2.5 μM), 0.5 μL sequencing buffer (2.5x), 1 μL of BigDye® 
Terminator v3.1 Cycle Sequencing Kit (normal deoxynucleotides, dye dideoxynucleotides, buffer 
and AmpliTaq DNA Polymerase, Applied Biosystems), 2.5 μL of purified product and 0.5 μL of 
water to complete the final volume. PCR sequencing process was performed for 35 cycles 
under the following conditions: 96ºC for 15 sec, 50ºC for 5 sec, and 60ºC for 2 min; a previous 
denaturation at 96ºC for 2 min and final extension at 60ºC for 10 min completed the reaction. A 
final purification step was performed in sequenced samples using Sephadex™ G-50 (GE 
Healthcare), a cross-linked dextran-gel used to separate the low (unincorporated nucleotides 
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and primers) from high molecular weight molecules of DNA (sequencing products). The 
products were purified through a Sephadex® column during 4 min at 4400 rpm, after an earlier 
centrifugation of 750 μL Sephadex® to form the columns. Finally, it was added 8 μL of HIDI™ 
formamide (Applied Biosystems) to the final product to increase the stability of single-stranded 
DNA for the capillary electrophoresis run in an ABI PRISM 3130x/Genetic Analyzer (Applied 
Biosystems). Sequences were analyzed with Sequencing Analysis v5.2 software (Applied 
Biosystems). 
 
7. Sex determination 
To assess the number of chromosomes analyzed of ATXN3L1, it was essential to know the 
gender of our individuals, since this gene is located in the X chromosome. Thus, we assessed 
other polymorphic loci located in the X chromossome, for which amplification had been 
previously optimized in our lab. Therefore, we genotyped seven polymorphic markers from the 
androgen receptor gene (Xq11-12): the (CAG)n region and 6 flanking STRs (short tandem 
repeats) [101]. Detection of PCR products has been done by capillary electrophoresis, through 
the use of a fluorescent forward primer for the amplification of each marker. The reaction was 
performed in a total volume of 10 µL containing 2x QIAGEN multiplex PCR Master Mix 1X, 0.5 
µL of each primer at 2.5 µM, 0.5x Q-solution, 1 µL of DNA, and 2 µL of H2O to complete the final 
volume. The (CAG)n amplification was perform using 6.25 µL of My Taq™ HS MIX, 1.25 µL of 
each primer, 1 µL of DNA, and 0.75 µL of H2O to complete the final volume of 10.5 µL. 
Amplification conditions and primates studied are organized in table 7. To perform capillary 
electrophoresis, 1 µL of the amplified product was mixed with 11.5 µL of HIDI™ formamide and 
0.5 µL of the internal marker GS-500 Liz (Applied Biosystems). The samples were run in an 
ABI-PRISM 3130 Genetic Analyzer system (Applied Biosystems) and the respective results 
were analyzed using GeneMapper Analysis Software v.4.0. We were not able to optimize the 
amplification of all samples for all markers which reduced the strength of our results. Thus, we 
tried to amplify the amelogenin gene located in the X chromosome (AMELX - Xp22.3-22.1) and 
its paralogue, the amelogenin-like gene (AMELY - Yq11), by adapting the protocol by Morrill et 
al. (2008) [102]; however, non-specificity did not allow us to amplify samples from our analyzed 
species. Then, we cut the gel fragment corresponding to our amplicon length, sequenced the re-
amplified products of the amelogenin gene and aligned the obtained sequences with AMELX 
and AMELY sequences of several primates available in public databases. 
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A. 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
  STR1 STR2 STR3 STR4 DXS1111 DXS1194 
Cercopithecus aetiops 62ºC 57ºC 62ºC ND ND 60ºC 
Hylobates 59ºC 57ºC ND ND 60ºC 60ºC 
Pygmaeus pongus 62ºC ND ND ND ND 60ºC 
Saguinus oedipus ND ND 58ºC ND ND 58ºC 
Macaca fuscata 2 59ºC 57ºC 62ºC ND ND 60ºC 
        (ND: Not determined) 
 
 
8. Multiple sequence alignment and neighbor-joining phylogenetic trees 
To study the origin of the retrotransposition events, we aligned all sequences available from the 
three genes under study (ATXN3, ATXN3L1 and ATXN3L2), either obtained at the lab or 
retrieved from public databases; we constructed a phylogenetic tree using the neighbor-joining 
method and the Tamura-Nei genetic distance model. The parental gene sequence of Canis 
familiaris was used as an outgroup. The (CAG)n region was removed since it represents a 
source of much variation as well as some incomplete sequences. Both alignments and 
phylogenetic trees were performed using Geneious Pro 5.5.8 software.  
 
 
Hold 1 Hold 3 Hold 2 
30x 
15’ 30’’ 
1’30’’ 
95ºC 94ºC 
wºC 
1’ 30’ 
60ºC 72ºC 
Hold 1 Hold 3 Hold 2 
38x 
15’ 30’’ 
1’30’’ 
95ºC 94ºC 
64ºC 
1’30’’ 10’ 
70ºC 72ºC 
Figure 8: Amplification conditions of the (CAG)n region in the androgen receptor gene with A. My Taq™ HS MIX; and B. QIAGEN 
Multiplex PCR Kit. 
Table 7: Annealing temperatures (w) used to amplify polymorphic markers located in the X chromosome for gender 
determination of some analyzed samples. 
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9. Phylogenetic analysis of selection (ω ratio calculations) 
Three different phylogenies were built using MEGA v5.1 software – one with ATXN3L1 
sequences alone, the second with ATXN3 sequences and a third with all sequences used in the 
previous phylogenies. ATXN3L2 displays a disrupted ORF, with maximum length fragments of 
200 bp predicted as alternative ORFs; for this reason this gene was not considered for the 
selection analysis. We discarded incomplete sequences and highly related species, leaving only 
those with ATXN3 and ATXN3L1 complete sequences (H. sapiens, P. troglodytes, G. gorilla, P. 
anubis, P. abelii, M. mulatta, N. leucogenys, and C. jacchus). To carry out a comprehensive 
analysis of our genes, all the sequences were verified for frameshift mutations and positions 
that did not align properly with any triplet were removed.  
Maximum likelihood estimates of dN/dS (ω) were carried out using the codeml program from the 
package Phylogenetic Analysis by Maximum Likelihood - PAML version 4.2. To test for variable 
selective pressures among branches, we performed the branch model using (1) the null or one-
ratio model, which assumes the same ω parameter for all branches; (2) the two-ratio model, 
which assumes one ω for the branch that predates the duplication event (i. e. ATXN3) and a 
second ω for the branch that follows the duplication event (i. e. ATXN3L1); and (3) the free-ratio 
model, which assumes an independent ω for all branches in the phylogeny, involving as many 
ω parameters as the number of branches [103, 104]. In addition, we performed site models, 
which allow the ω value to vary among sites of the protein and compared models of neutrality 
with positive selection (M1 vs M2 and M7 vs M8) [105, 106]. Finally, to evaluate lineage-specific 
changes at amino acid sites, we performed the branch-site model. This model assumes that the 
branches on the phylogeny are divided a priori into foreground (ATXN3L1) and background 
(ATXN3) and allows ω to vary both among sites in the protein and across branches [107]. The 
significance of each nested model was obtained from twice the variation of likelihoods (2Δl) 
using a 2 statistic. 
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10. Transcriptional pattern of ATXN3L1 in human tissues 
10.1 RT-PCR 
To evaluate if ATXN3L1 was transcribed, we first performed a transcriptase reverse PCR using 
QuantiTect® Reverse Transcription kit (QIAGEN) and mRNA samples of 20 different human 
tissues namely: ovary, bladder, trachea, esophagus, thymus, thyroid, colon, kidney, skeletal 
muscle, testis, small intestine, heart, spleen, prostate, liver, brain, placenta, cervix, lung, and 
adipose tissue (Ambion® FirstChoice® Human Total RNA Survey Panel). 
We started with the genomic DNA elimination by mixing 1 µg of our RNA with 2 µL of gDNA 
wipeout buffer 7x and 11 µL of RNase-free water, obtaining a total volume of 14 µL that was 
incubated for 2 min at 42ºC. To this template RNA we added a reverse-transcription master mix 
(1 µL of Quantiscript Reverse Transcriptase, which contained RNase inhibitor also; 4 µL of 
Quantiscript RT Buffer 5x, containing Mg2+ and dNTPs, 1 µL of RT Primer Mix) and incubated at 
42ºC for 30 min. Finally, to inactivate the Quantiscript Reverse Transcriptase, samples were 
submitted to 95ºC for 3 min. All the reactions were performed on ice. 
 
10.2 Amplification 
Primers were previously design in regions flanking the exon junctions of the corresponding 
ATXN3 exons determined by aligning the ATXN3L1 sequence with the concatenated exons of 
parental ATXN3; this way, the exons’ limits of the parental gene were annotated in the retrocopy 
[32]. 
 
 
 
 
 
 
 
 
Primer Sequence Amplicon size (bp) 
E7-8F  CAGTGTCGAAGAGATGGATAC 
140 
E7-8R CCTCATCTTGGTCTGATGTTCCAGACT 
Table 8: Primers designed to specifically amplify ATXN3L1 in human cDNA. 
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Figure 9:  ATXN3 gene structure and primers insertion location. Transcribed regions are represented in blue, and not-transcribed 
and UTR regions in grey. (Adapted from Bettencourt et al., 2011) [26]. 
 
 
We performed a duplex PCR amplification by using 5 µL of My Taq™ HS MIX, 0.5 µL of each 
primer (2.5 µM), 1 µL of our cDNA and 2 µL of H2O to complete the final volume of 10 µL. The 
PCR conditions included an initial denatured process at 95ºC for 15 min, a final extension at 
60ºC for 30 min and 35 intermediate cycles at 94ºC for 30 sec, 59ºC for 90 sec and 72ºC for 30 
sec. The GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene was used as positive 
control since it is ubiquitously expressed and one of the most commonly used housekeeping 
genes in comparisons of gene expression data [108]. Finally, we confirmed specific 
amplifications by polyacrylamide gel electrophoresis followed by silver staining. 
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1. Evolution of the (CAG)n tract in ATXN3, ATXN3L1 and ATXN3L2 
To gain insight into the processes by which the (CAG)n tracts have been accumulating variation 
throughout the evolution of each paralogue, we analyzed sequences from all primates obtained 
from databases and in our lab (Table 9).  
While analyzing the compiled sequences, we observed the (CAG)n tract conserved in the 
parental gene along the primate lineage, except in the two orangutans (Pongo abelii and 
Pygmaeus pongus), which presented several interruptions of triplets coding lysine or 
phenylalanine. In humans (Homo sapiens), chimpanzees (Pan troglodytes and Pan paniscus), 
gorilla (Gorilla gorilla), baboon (Papio anubis), rhesus monkey (Macaca mulatta), and African 
green monkey (Cercopithecus aetiops), a (CAG)2 CAA AAG CAG CAA tract is followed by AAG 
and/or (CAG)n; in cynomolgous monkey (Macaca fascicularis) some point mutations originated 
the tract (CAG)2 CAA (CAG)2 AAG (CAG)7. Both configurations give rise to an almost pure 
polyQ tract, with a single lysine (K) interruption (two in gorilla, baboon and African green 
monkey). The (CAG)n tract in bushbaby has a (CAG)n CAA (CAG)n, followed by a AAG. The 
protein tract is almost pure in this species presenting only a terminal lysine. Gibbon (Nomascus 
leucogenys) and marmoset (Callithrix jacchus) present an almost pure polyQ stretch with one 
and two glutamic acids (E) interruptions, respectively. Squirrel monkey (Saimiri boliviensis) and 
tarsier (Tarsius syrichta) are the only species analyzed with a pure polyQ stretch. 
For ATXN3L1, the repetitive region is also conserved among primates, with a (CAG)2 GAA CAG 
AAG (CAG)2 (CAA)2 CAG tract observed in several species. The resulting putative protein 
sequence is interrupted, generally with the Q2 E Q K Q5 configuration. Gorilla and orangutan 
have a slightly different configuration which gives rise to an additional leucine (L) before the last 
group of four glutamines. The owl monkey (Aotus trivirgatus), squirrel monkey, marmoset, and 
cotton-top tamarin (Saguinus oedipus) present a highly interrupted tract: GAG CAA GAA CAA 
(CAG)2 AGG AAA CAA AAG, giving rise to the interrupted polyQ stretch E Q E Q3 R K Q K. 
Tarsier is the only species presenting a small pure polyQ tract for ATXN3L1 of just four 
glutamines. The chimpanzee sequence obtained from Ensembl present a different (CAG)n tract 
from the other 3 individuals  sequenced by us, with a CAC instead of a CAA in the 3’-end of the 
repeat.  
As for ATXN3L2, translated products have not been considered since it presents a disrupted 
ORF. Thus, we observed a pure (CAG)n tract in gorilla, orangutan and gibbon, whereas in 
humans and chimps it is highly interrupted by CGG triplets. For the first time, a hexanucleotide 
repeat is observed in ataxin-3 paralogues, instead of a trinucleotide pattern. By comparing both 
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retrocopies, ATXN3L1 acquired more interruptions in its CAG repeat region than ATXN3L2, 
which turned it more stable. Accordingly, the almost pure ATXN3L2 tract in species which 
diverged earlier in primate evolution, and the polymorphic (CGG CAG)n in humans and chimps 
show the higher instability associated to this locus in comparison to both parental ATXN3 and 
ATXN3L1 retrogene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*ATXN3L2 presents a disrupted ORF 
 
 
 
 
Table 9: ATXN3, ATXN3L1 and ATXN3L2 (CAG)n tracts obtained both from public databases and our sequencing of several primates. N 
represents the number of chromosomes analyzed. 
N Sequence N Sequence N Sequence
(CAG)2 CAA AAG CAG CAA (CAG)n (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 
Q3 K Qn Q2 E Q K Q5
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
(CAG)2 CAA AAG CAG CAA (CAG)12  Q2 E Q K Q5
Q3 K Q14  (CAG)2 GAA CAG AAG (CAG)2 CAA CAC CAG
Q2 E Q K Q3 H Q
(CAG)2 CAA AAG CAG CAA (CAG)11 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
Q3 K Q13 Q2 E Q K Q5
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
(CAG)2 CAA AAG CAA AAG (CAG)4 Q2  E  Q  K  Q5
Q3 K Q K Q4 (CAG)2 GAA CAG AAG CTG CAG (CAA)2 CAG
Q2  E  Q  K  L  Q4
(CAG)2 CAA AAG CAG CAA (CAG)2 CCG CAA AAG CAG CAA (CAG)2 CCG CAA (CAG)9  (CAG)2 GAA CAG AAG CTG CAG (CAA)2 CAG 4 (CAG)6
Q3 K Q4 P Q K Q4 P Q10 Q2 E Q K L Q4 1 (CAG)7
(CAG)2 CAA AAG CAG CAA (CAG)2 CCG CAA (CAG)2 CAA (CAG)2 CCG CAA (CAG)7 (CAG)2 GAA CAG AAG CTG CAG (CAA)2 CAG
Q3 K Q4 P Q6 P Q8 Q2 E Q K L Q4
(CAG)3 CAA (CAG)5 GAG (CAG)3 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
Q9 E Q3 Q2 E Q K Q5
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
Q2 E Q K Q5
(CAG)2 CAA AAG CAG CAA (CAG)2 AAG (CAG)7 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 3 (CAG)7 CAC CAG
Q3 K Q4 K Q7 Q2 E Q K Q5 3 (CAG)8 CAC CAG
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
Q2 E Q K Q5
(CAG)2 CAA (CAG)2 AAG (CAG)7  (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 13 (CAG)6 CAC CAG
Q5 K Q7 Q2 E Q K Q5 2 (CAG)7 CAC CAG
(CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
Q2 E Q K Q5
(CAG)2 CAA (CAG)2 AAG (CAG)7  (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG 5 (CAG)6 CAC CAG
Q5 K Q7 Q2 E Q K Q5 3 (CAG)8 CAC CAG
(CAG)2 CAA AAG CAG CAA  (CAG)13 AAG  (CAG)6 (CAG)2 GAA CAG AAG (CAG)2 (CAA)2 CAG
Q3 K Q15 K Q6 Q2 E Q K Q5
 GAG CAA GAA CAA (CAG)2 AGG AAA CAA AAG
E Q E Q3 R K Q K
CAG CAA (CAG)5 (CAA)5 CAG CAA (CAG)12 GAG CAA GAA CAA (CAG)2 AGG AAA CAA AAG
Q26  E Q E Q3 R K Q K
CAG CAA (CAG)5 CAA (CAG)3 GAG (CAG)3 GAG (CAG)3  GAG CAA GAA CAA (CAG)2 AGG AAA CAA AAG
Q11 E Q3 E Q3  E Q E Q3 R K Q K
GAG CAA GAA CAA (CAG)2 AGG AAA CAA AAG
 E Q E Q3 R K Q K
(CAA)2 (CAG)2 CAG CAA (CAG)2
Q4 Q4
(CAG)5 CAA (CAG)5 AAG
Q11 K
Tarsius syrichta
Otolemur garnettii 1
1 1
Macaca fascicularis
Saimiri boliviensis 
Callithrix jacchus
Saguinus oedipus
1
1
6
1
1
11
Pongo abelii 
Papio anubis 
2
1
2
ATXN3L2*ATXN3
36
1
1
2 9 (CAG)6-17
1
1
1
1
3
2
ATXN3L1
Gorilla gorilla
Pygmaeus pongus
Nomascus leucogenys
Hylobates 
Homo sapiens
Pan troglodytes
Pan paniscus
98
1
1
4
1
2
(CAG)6 CAC CAG2
30
1
2
1
Cercopithecus aethiops
Aotus trivirgatus
Papio hamadryas
2
1
2
Macaca fuscata
2
6
Macaca mulatta
CAG (CGGCAG)5 GGG CAG (CGGCAG)3 GGG CAG
6 CAG (CGGCAG)3-9 GGG CAG
58 (CAG)3 (CGG CAG)4-11
(CAG)6 CAC CAG
(CAG)6
(CAG)8
(CAG)3 CAA (CAG)2
30
1
1
1
4
GAG (CAG)4 CAA 1
2 GAG (CAG)3 CAA
GAG (CAG)3 CAA
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AMELX  
AMELY  
AMELY  
AMELX  
2. Sex determination  
We determined the gender of primates for which this information was lacking. First, we 
genotyped the androgen receptor gene based on the theoretical basis of observing 
homozygozity in males and heterozygozity in females, since AR is located in the X 
chromosome. The successful genotyping of four AR polymorphic markers by capillary 
electrophoresis was not enough to determine the sex of all the primates (Table 10).  
Then, we tried to differentiate the allelic states of the X/Y polymorphism in the amelogenin gene 
by electrophoresis; the presence of one or two fragments 6 bp distance of each other would 
identify a female or a male, respectively. All 5 samples analyzed by us appeared to present a 
single length fragment which led us to suspect that our electrophoresis conditions did not allow 
the correct visualization of the two allelic states of this Indel. Thus, we proceeded with the 
sequencing of the AMELX/Y amplified products and aligned with reference sequences (Figure 
10). The identification of a 6 bp insertion in AMELY, together with additional AMELX/Y specific 
point variants across the sequence, allowed us to determine the gender of our primate samples 
as shown in the appendix section (Table A1). 
 
 
 
CAG STR1 STR3 DXS1194 
Cercopithecus aetiops h H h H 
Hylobates h ND ND H 
Pygmaeus pongus h h ND h 
Saguinus oedipus h ND ND ND 
Macaca fuscata 2 h H H H 
                                                 H – heterozygous sequence; h – homozygous sequence; ND – not  
                                                determined. 
A. 
  
 
B. 
 
 
 
3. Intraspecific ATXN3L1 duplication events 
Table 10: Capillary electrophoresis results for four polymorphic 
markers within or flanking the androgen receptor gene. 
 
Figure 10: Alignment of AMELX and AMELY sequences with A. a male chimpanzee control sample; and B. a female owl monkey 
control sample. 
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3. Intraspecific ATXN3L1 duplication events 
After confirming the gender of the 15 Macaca fuscata samples, we noticed that all individuals 
showed to be heterozygous for at least one ATXN3L1 position, including all 5 males. In total, we 
identified 7 different patterns with 4 SNPs as represented in table 11 and figure 11. Results 
have been confirmed in all specimens by sequencing in both forward and reverse directions. We 
therefore, hypothesized that a duplication of the ATXN3L1 locus occurred in this species or in a 
common recent ancestor of Old World monkeys. Interestingly, we noticed that in some 
sequences there was a different proportion of each nucleotide (Figure 11- B). This could be due 
to preferential annealing of specific primers designed for ATXN3L1 in the amplification or in the 
sequencing reaction. Yet, the patterns remained constant through the several PCR and 
sequencing replications. 
 
 
 
                        Table 11: Heterozygozity pattern and polymorphic positions of M. fuscata ATXN3L1. 
  
Variant 
 
Specimen Sex c.561T>G c.743A>G c.923A>C c.995C>T Pattern 
M. fuscata 1 Female T G A/C C/T 1 
M. fuscata 2 Female T G A/C C/T 1 
M. fuscata 3 Male T G A C/T 2 
M. fuscata 4 Male T A/G A/C C/T 3 
M. fuscata 5 Female T G A C/T 2 
M. fuscata 6 Male T A/G A/C C/T 3 
M. fuscata 7 Female T G A/C C/T 1 
M. fuscata 8 Female T G A C/T 2 
M. fuscata 9 Female T/G G A C/T 7 
M. fuscata 10 Female T G A/C C/T 1 
M. fuscata 11 Female T G A C/T 4 
M. fuscata 12 Male T G A C/T 2 
M. fuscata 13 Female T A/G A/C C/T 6 
M. fuscata 14 Female T G A C/T 5 
M. fuscata 15 Male T A/G A/C C/T 3 
 *in bolt are represented alleles with the highest intensity in sequencing. 
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A. 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
Pattern 1 
 
Pattern 2 
 
Pattern 3 
 
Pattern 4 
 
Pattern 5 
 
Pattern 6 
 
Pattern 7 
 
  
c.561T>G c.743A>G c.923A>C c.995C>T 
Figure 11: Example of two ATXN3L1 variant positions in M. fuscata. The two sequences represented in each image (A and B) were 
sequenced at different time courses and by using alternative primers (forward and reverse) to assure the reproducibility of results; A. 
Heterozygous position c.995C>T in M. fuscata 8; B. Heterozygous position c.923A>C in M. fuscata 10 showing the two nucleotides 
unequally represented. 
Figure 12: The different patterns of heterozygozity found in M. fuscata samples while sequencing ATXN3L1. The four nucleotides 
are distinguished by four different colours (red – adenine; blue – cytosine; green – timine; and yellow – guanine). 
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As for the other Macaca we found two heterozygous position in two M. fascicularis  males  
sequenced by us (with c.995C>T corresponding to M. fuscata c.995C>T), although in this case 
a pattern could not be established due to the low number of analyzed chromosomes (6). On the 
other hand, our data did not allow us to confirm if this duplication is present or not in M. mulatta 
since no biallelic states have been found in the four males sequenced. For this species, a single 
heterozygous position has been observed in a female individual (c.174C>T). 
We also found a duplication of the ATXN3L1 locus in Papio anubis. Using the Blat tool in UCSC 
Genome Browser, we found two sequences located in the X chromosome with 92% similarity to 
human ATXN3L1. By analyzing our sequencing results of three baboon samples, we observed 
a male with 4 positions with 2 allelic states, and noticed that these heterozygous positions 
corresponded to the bases varying between UCSC sequences ChrX: 10617308-10618372 and 
ChrX: 10636574-10637639 (Table 12). We aligned the two P. anubis sequences retrieved from 
UCSC with all other ATXN3L1 orthologues and confirmed that both clustered with other 
ATXN3L1 sequences and shared a common node, suggesting a recent duplication event of this 
locus. 
 
 
 
Table 12: ATXN3L1 polymorphic positions found in Papio anubis. 
Origin Sequences Sex Variant 
   
c.280C>T c.319A>G c.987A>T c.1006A>G c.1007C>T c.1011C>T 
UCSC 
P. anubis (ChrX: 10617308-10618372) Unknown T G T A T C 
P. anubis (ChrX: 10636574-10637639) Unknown C A A G C T 
Our 
samples 
Baboon 1 Female C/T A/G A/T A/G C/T C/T 
Baboon 2 Female C/T A/G A/T A/G C/T C/T 
Baboon 3 Male ND ND A/T A/G C/T C/T 
ND: not determined 
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4. ATXN3L2 in Aotus trivirgatus 
Several sequences highly homologous to the human ATXN3 CDS available in public databases 
have been identified by us as independent-origin retrocopies of ATXN3 [32]. When using 
different sets of primers in the optimization of ATXN3L2 amplification in Aotus trivirgatus, we 
found two different sequences with high similarity to human ATXN3L2. The multiple sequence 
alignment followed by neighbor-joining phylogenetic tree allowed us to identify A. trivirgatus 
ATXN3L2 whereas the second sequence (here named ATXN3L?) showed a closer molecular 
distance with other recent retrocopies of ATXN3. Indeed, results showed ATXN3L? sharing a 
more common recent ancestor with parental genes than with ATXN3 paralogues, as we can see 
in figure 14. 
 
 
 
 
 
Figure 13: Neighbor-Joining phylogenetic tree for ATXN3 and ATXN3L1 showing the two sequences retrieved from UCSC to Papio 
anubis. 
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5. Origin of the retrotransposition events 
To estimate the time for the origin of ATXN3 paralogues, we constructed phylogenetic trees 
including all species in which the three genes have been identified. The alignment and 
respective tree has been done after removing the (CAG)n tract, since it usually represents a 
source of much variation generated by a still unknown process (most likely to be independent 
from the locus evolution). As shown in figure 15, ATXN3L1 is present in the entire clade of 
Haplorrhines but absence in Strepsirrhines. The ATXN3L2 is present only in the Anthropoid 
clade. Thus, ATXN3L1 and ATXN3L2 seem to have independent origins about at least 63 MYA 
(before the split between Tarsiers and Anthropoids) and 43 MYA (before Platyrrhine and 
Catarrhine split from their ancestor), respectively, based on the tree of species (Figure 16) and 
respective divergence times [109]. The most common ATXN3 transcript, ATXN3-001, seems to 
be in the origin of ATXN3L1 and ATXN3L2 given the high similarity between these retrogenes 
and ATXN3-001 over all the other transcripts [32].  
 
Figure 14: Neighbor-Joining phylogenetic tree showing ATXN3 and ATXN3L2 in several primates, and evidencing the origin of 
Aotus trivirgatus ATXN3L2 and ATXN3L? sequences. 
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ATXN3L2 is present in tamarin but we were not able to amplify this gene in marmosets (Figure 
16). Taking into account that both are New World monkeys, problems in the annealing of our 
primers in the Callithrix species seem more likely than the absent of ATXN3L2 in marmosets. 
Thus, further optimizations need to be done in order to amplify and sequence this gene in our 
Callithrix jacchus samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Neighbor-Joining phylogenetic tree for ATXN3, ATXN3L1, and ATXN3L2. Canis familiaris was used as an outgroup. 
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6. Phylogenetic analysis of selection 
Evolutionary pressures on proteins have been quantified by calculating the omega ratio (ω) for 
ATXN3 and ATXN3L1, using the coding sequences of eight primate species: H. sapiens, P. 
troglodytes, G. gorilla, P. abelii, N. leucogenys, P. anubis, M. mulatta, and C. jacchus. We 
assured a close agreement between gene tree and species tree. 
 
 
 
Figure 16: Phylogenetic tree of primates. The presence of ATXN3L1 and ATXN3L2 is marked in each species with a red and a 
blue dot, respectively. The blue and red stars represent the time at which ATXN3L2 and ATXN3L1 may have been originated. 
(Adapted from http://whozoo.org/mammals/Primates/primatephylogeny.htm). 
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6.1 Branch models 
To address the extent of the selective pressures exerted on ATXN3 and ATXN3L1, we 
performed branch models and tested whether these genes experienced different selective 
pressures during primate evolution. First, we estimated a single ω for the entire phylogeny (one-
ratio model), in which we assumed no differentiation in ATXN3 and ATXN3L1 selective 
constraints over evolution. The observed ω value below 1 (ω=0.30) pointed out to an overall 
conservation of ATXN3 and ATXN3L1 (Table 13). Then, to examine whether the two genes 
were subjected to different selective pressures, we applied a different model (two-ratio model) 
considering two branches within the phylogeny comprising either ATXN3 or ATXN3L1. Both ω 
values were below 1 (ωATXN3=0.17; ωATXN3L1=0.33) (Table 13) but differed significantly from the 
previous reported model (-2Δl=8.89; P<0.05), indicating that ATXN3 (ω=0.17) has been under 
stronger constraints than ATXN3L1 (ω=0.33). 
 
 
 
     *Extremely significant (P<0.01; 2 = 6.6) 
 
 
 
 
 
Model Likelihood (ln) Parameters 
One-ratio (M0) -3630.56 ω=0.30 
 ATXN3 = -1764.34 ω=0.17 
 ATXN3L1 = -2631.58 ω=0.33 
Two-ratios -3626.11 ωATXN3=0.15 
ωATXN3L1=0.34 
 
                   Free-ratio                 ATXN3 = -1755.55  
               ATXN3L1 = -2622.20  
Models compared df -2Δl Critical 
2
 values (P=0.05) 
One-ratio vs Two-ratios 1 8.89* 3.84  
One-ratio vs Free-ratio (ATXN3) 12 17.59 21.03  
One-ratio vs Free-ratio(ATXN3L1) 12 18.75 21.03  
Table 13: Parameter estimates and likelihood scores under different branch models. Model comparisons of variable ω ratios 
among branches. 
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B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Phylogeny of the 8 primate species analyzed. Branches are drawn in proportion to their lengths, defined as the expected 
numbers of nucleotide substitutions per codon and estimated using the one-ratio model, which assumes the same dN/dS ratio for all 
branches in the tree [110]. The ω values presented here were determined in free-ratio model for A. ATXN3; and B. ATXN3L1. 
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6.2 Site models 
In order to test if different selective pressures had been acting along the protein sequence, we 
performed several site models. In these cases, variable ω ratios among sites were calculated 
for each gene and neutral and selection models compared (M1 vs. M2 and M7 vs. M8). We 
observed that in both cases, neutral models fit better the ATXN3 and ATXN3L1 data than 
positive selection models (Table 14). This shows that there may not be a large category of 
amino acid sites in our genes where non-synonymous substitutions occur at a higher rate than 
synonymous substitutions. 
 
 
Table 14: Parameter estimates and likelihood scores under different site models. Model comparisons of variable ω ratios among 
sites. 
 
Model Likelihood (ln) Parameters 
ATXN3 
M1 -1764.22 p1=0.96 ; p2=0.04  
 
  ω1=0.14 ; ω2=1.00 
M2 -1764.22 p1=0.96 ; p2=0.00 ; p3=0.04  
 
  ω1=0.14 ; ω2=1.00 ; ω3=1.00 
M7 -1764.17  p1=p2=p3=p4=p5=p6=p7=p8=p9=p10=0.10 
  
ω1=0.00 ; ω2=0.01 ; ω3=0.03 ; ω4=0.06 ; ω5=0.10 ; ω6=0.14 ; ω7=0.19 ; 
ω8=0.26 ; ω9=0.37 ; ω10=0.55 
M8 -1764.17 p1=p2=p3=p4=p5=p6=p7=p8=p9=p10=0.10 ; p11=0.00 
  
ω1=0.00 ; ω2=0.01 ; ω3=0.03 ; ω4=0.06 ; ω5=0.10 ; ω6=0.14 ; ω7=0.19 ; 
ω8=0.26 ; ω9=0.37 ; ω10=0.55 ; ω11=1.00 
ATXN3L1 
M1 -2627.39 p1=0.81 ; p2=0.19  
 
  ω=0.21 ; ω=1.00 
M2 -2627.18 p1=0.90 ; p2=0.00 ; p3=0.10  
 
  ω1=0.25 ; ω2=1.00 ; ω3=1.52 
M7   -2627.89  p1=p2=p3=p4=p5=p6=p7=p8=p9=p10=0.10 
  
ω1=0.01 ; ω2=0.05 ; ω3=0.11 ; ω4=0.18 ; ω5=0.27 ; ω6=0.36 ; ω7=0.46 ; 
ω8=0.58 ; ω9=0.72 ; ω10=0.88 
M8 -2627.18 p1=p2=p3=p4=p5=p6=p7=p8=p9=p10=p11=0.09 
  
ω1=0.20 ; ω2=0.22 ; ω3=0.23 ; ω4=0.24 ; ω5=0.25 ; ω6=0.26 ; ω7=0.27 ; 
ω8=0.28 ; ω9=0.29 ; ω10=0.32 ; ω11=1.54 
 
Models 
compared 
df -2Δl Critical 
2
 values (P=0.05) 
ATXN3 
M1 vs M2 
2 
0.00 
5.99 
M7 vs M8 0.00 
ATXN3L1 
M1 vs M2 
2 
0.41 
5.99 
M7 vs M8 1.41 
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6.3 Branch-site model 
To test if some codons of ATXN3L1 have been evolving differently in different lineages, we 
applied the branch-site model, in which branches on the phylogeny are divided a priori into 
foreground (ATXN3L1 branch) and background (ancestral ATXN3 branch) and selective 
pressures are allowed to vary over sites and branches. All sites seem to be constrained or 
neutrally evolving with ω values always below or equal 1 (Table 15). Given these results, we 
decided to define the duplication branch as our foreground and all the other branches as 
background to test whether a faster evolution has happened right after de retrotransposition 
event. Once more, no significant values were found.  
 
 
Table 15: Parameter estimates and likelihood scores under different branch-site models. Model comparisons of variable ω ratios 
among sites and branches. 
Model Initial ω Likelihood (ln) Parameters 
 1 (fixed) -3614.52 p= 0.69 0.00   0.31  0.00 
H0   ωATXN3= 0.15 1.00   0.15   1.00 
   ωATXN3L1= 0.15   1.00  1.00   1.00 
       
 
0 -3614.52 p= 0.69 0.00   0.31  0.00 
  ωATXN3= 0.15 1.00   0.15   1.00 
  ωATXN3L1= 0.15   1.00  1.00   1.00 
1 -3614.44 p= 0.68  0.01   0.30   0.01 
  ωATXN3= 0.15   1.00  0.15   1.00 
   ωATXN3L1= 0.15  1.00   1.00   1.00 
H1 2 -3614.44 p= 0.68  0.01   0.30   0.01 
   ωATXN3= 0.15   1.00  0.15   1.00 
   ωATXN3L1= 0.15  1.00   1.00   1.00 
 4 -3614.52 p= 0.69 0.00   0.31  0.00 
   ωATXN3= 0.15 1.00   0.15   1.00 
   ωATXN3L1= 0.15   1.00  1.00   1.00 
 5 -3614.44 p= 0.68  0.01   0.30   0.01 
   ωATXN3= 0.15   1.00  0.15   1.00 
   ωATXN3L1= 0.15  1.00   1.00   1.00 
Models compared 
df 
 
-2Δl Critical 
2
 values (P=0.05) 
H0 vs H1 (0) 
1 
0.00 
3.84 
H0 vs H1 (1) 0.14 
H0 vs H1 (2) 0.14 
H0 vs H1 (4) 0.00 
H0 vs H1 (5) 0.14 
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7. Nucleotide diversity of ATXN3L1 and ATXN3L2 
By analyzing intraspecific nucleotide diversity, we observed that for ATXN3L1, gorilla (G. gorilla) 
presented the highest number of polymorphisms (26) followed by chimpanzee (P. troglodytes) 
(11), baboon (P. anubis) (6), japanese macaque (M. fuscata) (4), orangutan (P. abelii) (3), and 
cynomolgous monkey (M. fascicularis) (2). In gorilla, 11 non-synonymous substitutions were 
observed, one of them leading to a premature stop codon 21 amino acids before the end of the 
putative protein. From the 11 polymorphisms found in chimpanzee, 10 were registered only due 
to the reference sequence retrieved from Ensembl Genome Browse (with 6 of them leading to 
non-synonymous substitutions, including a premature stop codon). Although the high similarity 
between our three chimpanzee samples, they are not related to the best of our knowledge. 
Orangutan showed one non-synonymous substitution over the 3 polymorphisms registered. In 
baboon, japanese macaque and cynomolgous monkey, we were not able disentangle between 
the condition of ATXN3L1 polymorphisms and sequence difference resulted from the ATXN3L1 
duplicate since all species have a highly homologous duplicate of this retrogene. Rhesus 
monkey (M. mulatta) and marmoset (C. jacchus) presented only one silent and one non-
synonymous polymorphism each, respectively. 
Considering ATXN3L2, gorilla was the species showing also the highest number of 
polymorphisms (41 in total), 4 of them indels (3 insertions and 1 deletion). Actually, deletions 
have also been found in rhesus monkey (which presented 12 polymorphisms in total, the same 
number as cynomolgous monkeys) and in orangutans (which had 3 additional SNPs). Baboon 
showed the longest sequence length variant: a 52 bp insertion in one of the 7 chromosomes 
analyzed (in addition to 5 SNPs). Neither chimpanzee nor japanese macaque presented length 
polymorphisms, but only 3 SNPs in 7 and 30 chromosomes analyzed, respectively. 
More details about this analysis can be retrieved from tables A3 and A4 in appendix. 
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8. Transcriptional pattern of ATXN3L1 
We tested the presence of ATXN3L1 transcripts in cDNA of different human body tissues as 
well as in chimpanzee brain by using primers designed to specifically amplify ATXN3L1 cDNA. 
Sequencing of the RT-PCR product obtained from human brain confirmed that amplified 
products were specific ATXN3L1 sequences, and not the parental ATXN3. Therefore, we 
observed that, in humans, ATXN3L1 is transcribed in testis, placenta, brain, spleen, and 
thymus. Testis and placenta were the tissues for which we observed more amplified product (a 
similar amplification pattern for GAPDH in all tissues discarded the possible heterogeneity in the 
cDNA quantity among different tissue samples). Although in a very lower intensity, we can still 
notice the presence of amplified product in trachea, skeletal muscle, prostate, lung, cervix, 
heart, bladder, and small intestine. 
Interestingly, we were also able to test transcription of ATXN3L1 in chimpanzee brain. 
Regarding the sequence conservation in the annealing region of E7-8 primers between human 
and chimpanzee ATXN3L1, we tested whether a functional gene was likely to be present in this 
non-human primate. Indeed, we have shown that ATXN3L1 is expressed in chimpanzee brain, 
although not so intensively as in humans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: ATXN3L1 transcriptional status of 20 human tissues and chimpanzee brain using E7-8 primers. GAPDH cDNA was 
amplified as a control. 
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Retrotransposition and retrogenes are gaining increasing attention as recent studies have 
shown that they may play an important role in genome evolution and in the formation of new 
genes [10]. Studies focusing on the modulation of parental genes by the respective expressed 
paralogues may be important to gain insight into the mechanisms by which ATXN3 retrocopies 
(especially ATXN3L1) may acquire functional relevance. In this study, we benefited from the 
existence of two paralogues of the ataxin-3 gene in the primate lineage, originated through 
retrotransposition, to analyze the mechanisms of (CAG)n evolution. This repetitive region is 
shared by all three paralogues, but expanded exclusively in the parental gene (ATXN3) of 
humans. Thus, by comparing variability patterns in the normal range of three highly similar 
genes (regarding the CDS or homologous sequence in ATXN3L2), which have been under 
different selective pressures can allow us the testing of hypotheses on the causes of expansion 
and disease. 
Andres et al. (2004) suggested that human capacity for expansion at repetitive loci could be 
explained by a higher variance and coefficient of variation observed in our species; thus, loci 
with increased variance may be more likely to expand and give rise to pathogenic alleles [111]. 
Still, one question remained: why do these disease associate repeats have higher variance than 
non-expanding loci? While analyzing the (CAG)n tract of our three paralogues in several 
primates, we noticed that a cassete-like structure is part of the ATXN3 orangutan and ATXN3L2 
chimpanzee sequences (Figure 19). These patterns have, more likely, resulted from unequal 
crossover events than from successive point mutations in a pure (CAG)n. Other less clear 
structures are found in the ATXN3 repeat of gorilla and marmoset and additional unequal 
recombination may have happened in other species, but no evidence can be noticed due to a 
pure nature of the tract. Similarly, unequal exchange of DNA during recombination may have 
underlain the evolution of other disease-associated repeats and still remain unnoticed due to the 
lack of interruptions that allow us to detect them. Actually, in polyalanine disorders, in which 
repetitive tracts are highly interrupted, unequal crossing-over is often mentioned as the main 
mechanism for the origin of newly sized alleles [112, 113]. 
 
A. 
A1 
 
 
A2 
 
CAG (CGGCAG)3 GGG CAG CGG 
CAG (CGGCAG)3 GGG CAG CGG 
CAG (CGGCAG)3 GGG CAG CGG 
CAG (CGGCAG)3 GGG CAG CGG 
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Figure 19: Schematic representation of the unequal crossing over events that may have led to the present (CAG)n tract in A. 
ATXN3L2 of Pan troglodytes; and B. ATXN3 of Pongo abelii. The red lines represent the chiasmata. 
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Our data suggested that the two retrocopies have independent origins: the ATXN3L1 about 63 
MYA, in the Haplorrhini clade, and ATXN3L2 about 43 MYA, before the Platyrrhine-Catarrhine 
split. Currently, a short CAA2 CAG2 is observed in Tarsier parental gene. Similarly, the 
ATXN3L1 orthologue has a CAG CAA CAG2 motif, but the acquisition of several interruptions 
seems to have occurred across the primate lineage. In fact, no more than two consecutive 
CAGs are observed, which turns this repeat less prone to instability. Although the function of the 
parental ATXN3 polyQ is poorly understood, it is interesting to notice that despite the repeat 
interruptions, ATXN3L1 of most primates may encode 5 consecutive glutamines in the 3'-end of 
its polyQ stretch. 
The ATXN3L2 pseudogene presents currently an almost pure (CAG)n in several species. 
Uninterrupted CAGs are also common to parental rodents and porcines homologous 
sequences, mammalian species prior to the second retrotransposition event on the origin of 
ATXN3L2 [114, 115]. This way, the repetitive tract has probably a pure nature on its origin that 
has been maintained throughout evolution in this non-functional gene. 
Some functions have been suggested to ATXN3 polyQ protein as transcriptional regulation, 
nuclear localization and protein-protein interactions [37]. A recent study has shown that species 
with high polyQ protein content have a higher number of proteins bearing domains with 
functions related to phosphatidylinositol (PI) signaling and ubiquitin-directed protein degradation 
[116]. As we know by then, aggregates containing proteins with an expanded polyQ stretch are 
ubiquitinated [95]. These facts suggest that (CAG)n tracts can actually be subjected to selective 
pressures, in order to maintain a possible functional role in the protein context. 
Interestingly, while completing data on ataxin-3 paralogous with our own sequencing, we were 
able to sequence a more recent ATXN3 retrocopy in owl monkey (Aotus trivirgatus). In fact, 
ATXN3 gene has been on the origin of many different retrocopies along the mammalian lineage 
[32] maybe due to the abundance of L1 retrotransposons in mammals [4, 5].  
In addition, we were able to find evidence of duplication events, occurred after the 
retrotransposition, in M. fuscata, M. fascicularis and P. anubis species. Given the high similarity 
between ATXN3L1 and the respective duplicate of each species shown in the obtained 
phylogenetic tree, we suggest that two different duplications have occurred after speciation 
(Figure 20). Actually, the ATXN3L1 genes of Papio anubis and Macaca species presented more 
nucleotide differences between them than between ATXN3L1 and the respective duplicate. 
Thus, it is more parsimonious that two different duplications have occurred than a single event 
followed by subsequent selective pressures acting similarly on both copies (ATXN3L1 and 
ATXN3L1 duplicate) of each species. 
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In M. fuscata, we tried to distinguish between ATXN3L1 and ATXN3L1 duplicate based on the 
seven different patterns found through the sequencing of 15 individuals. We started by 
comparing the heterozygous with homozygous non-variable positions. Then, we compared also 
ATXN3L1 sequences of other primates to infer the ancestral allele, i.e. the ATXN3L1 allele. In 
cases where we found different nucleotide proportions in sequencing, the ancestral allele was 
considered as being in ATXN3L1 sequence and the derived allele in the duplicate sequence. 
This way, we were able to discern that two heterozygous positions (c.743A>G and c.923A>C) 
were indeed polymorphic in the duplicate, and one position (c.995C>T) was polymorphic in both 
ATXN3L1 and ATXN3L1 duplicate (Figure 21 - A). The fluorescence imbalance in the 
sequencing suggests that the ATXN3L1 duplicate is, as well, located in the X chromosome.  
We did the same exercise to M. fascicularis and found alleles A and T to be the ancestral alleles 
of c.801A>C and c.995C>T, respectively (Figure 21 - B). 
 
 
 
 
 
 
 
Figure 20: Phylogenetic tree showing the species where duplications of ATXN3L1 seem to have 
occurred. The red stars represent the duplication events. Hylobates was used as an outgroup. This 
tree was obtained from Geneious sotware using neighbor-joining method. 
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A. 
Pattern 1 (4 females) Pattern 2 (2 males and 2 females)  
 
 
 
 
 
Pattern 3 (3 males) Pattern 4 (1 female) Pattern 5 (1 female) 
 
 
 
 
 
Pattern 6 (1 female) Pattern 7 (1 female) 
 
 
 
 
 
B. 
Cynomolgous monkey 1 (male)                         Cynomolgous monkey 2 (male) 
 
 
 
 
 
 
 
Regarding the divergent positions in P. anubis, we could not infer haplotype phases for 
ATXN3L1 and ATXN3L1 duplicate since both sequences retrieved from the UCSC database 
seem to contain ancestral alleles at different positions (Table 16). 
T-G-A-T 
T-G-A-C 
T-G-A-T 
T-G-C-C T-G-A-C 
T-G-A-T 
T-G-A-C T-G-A-C 
T-G-A-T T-G-A-T 
T-G-A-T 
T-A-C-C 
T-G-A-T 
T-G-A-C T-G-A-C 
T-G-A-C 
T-G-A-T T-G-A-C 
T-G-A-T T-G-A-T 
T-G-A-C T-A-C-C 
T-G-A-T T-G-A-T 
G-G-A-T G-G-A-C 
T-G-A-T T-G-A-T 
C-T 
A-T 
A-C 
A-T 
Figure 21: ATXN3L1 (L1) and ATXN3L1 duplicate (dL1) haplotypes for A. positions c.561T>G, c.743A>G, c.923A>C and c.995C>T 
in M. fuscata individuals; and B. c.801A>C and c.995C>T in M. fascicularis males. 
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Table 16: Inferred ancestral alleles for ATXN3L1 in P. anubis based on orthologous sequences observed in other primates. 
Sequences Variant 
 
c.280C>T c.319A>G c.987A>T c.1006A>G c.1007C>T c.1011C>T 
P. anubis (ChrX: 10617308-10618372) T G T A T C 
P. anubis (ChrX: 10636574-10637639) C A A G C T 
Ancestral allele T A T G C C 
 
 
Analyzing the nucleotide diversity of ATXN3L1 within each of these three species (M. fuscata, 
M. fascicularis and P. anubis) no differences were found besides those related to the ATXN3L1 
duplicates. In fact, most species present low interspecific diversity, although there is the 
possibility of underestimating variance due to sampling from a single, localized population or 
inbred zoo collection, which is, for instance, the case of M. fuscata. According to Ensembl 
database, only 6 positions are indicated as polymorphic in P. troglodytes. We were able to find 
up to 10 SNPs for this species, when comparing our sequences to that from Ensembl, leading 
us to suppose that our samples, even unrelated, may be from a very different population. From 
all the species analyzed, G. gorilla is the only presenting a high intraspecific diversity for 
ATXN3L1. For ATXN3L2, a higher variance was found within species including not only SNPs 
but also indels for at least 4 species. This may due to the fact that ATXN3L2 presents a highly 
interrupted ORF and also is located into an autosome, which is much subjected to 
recombination than a sexual chromosome. 
The synonymous to non-synonymous substitution rate (dN/dS=ω) is a measure of the proportion 
of mutations in DNA sequence that also alter amino acid sequence; it is often used to assess 
whether a sequence is under evolutionary constraint, being an indicator of functionality [3]. In 
general, a dN/dS ratio that is significantly lower than unity is considered to indicate functional 
constraint and ω values above unity indicates positive selection [72]. 
We performed a series of branch, site and branch-site models to test the conservative 
hypothesis of ATXN3L1 and whether ATXN3 and ATXN3L1 experienced different selective 
pressures during primate evolution. 
ATXN3 and ATXN3L1 are highly conserved in the primate lineage (ω=0.17 and ω=0.33, 
respectively), but a scenario of functional divergence after the transposition should be 
considered since different selective pressures for ATXN3 and ATXN3L1 have been detected 
(two-ratio test fits our data better than one-ratio). In fact, ATXN3 has been under stronger 
constraints than ATXN3L1. This difference does not seem to result from variation across the 
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sequence since we have found uniform selective pressures among sites for both genes. 
Actually, neutral models fit better the ATXN3 and ATXN3L1 data than positive selection models.  
Genomic context has been found to affect the rate of duplicate gene evolution.  In general, 
retrogenes seem to evolve faster than their parent genes, although this reflects broad trends 
rather than gene-by-gene studies [117]. According to our branch-site models results, all sites in 
both paralogues and lineages seem to be equally constrained or neutrally evolving. 
We next wanted to confirm the evidence of ATXN3L1 functional relevance by analyzing its 
transcription. In the NCBI – UniGene – EST Profile, ATXN3L1 expression has been registered 
in human testis and brain, with higher levels of expression in testis. Our results have shown, 
however, that human ATXN3L1 is also transcribed in placenta, spleen, and thymus, bringing a 
new insight into the functional relevance of this paralogue. It is also interesting to notice that a 
slight fraction of this paralogue transcript could be found in trachea, skeletal muscle, prostate, 
lung, cervix, heart, bladder, and small intestine. In chimpanzee, we were able to confirm 
ATXN3L1 expression in brain, the most important tissue in the context of the human Machado-
Joseph disease. 
It has been shown that retrogenes are not randomly located on chromosomes with a significant 
excess of retrogenes that originate from the X chromosome and retroposed to autosomes [13, 
14]. Regarding the recruitment of retrogenes, the X chromosome is the only outlier in the 
genome since it accepts an excess of functional copies from autosomes [14]. Functional genes 
disproportionately enter the X chromosome compared with nonfunctional genes most probably 
due to natural selection favoring the fixation and maintenance of retrogenes. Therefore, it is 
interesting to notice that the most conserved ATXN3 retrocopy, ATXN3L1, is located on the X 
chromosome. 
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Most of the aims established for this thesis have been achieved, yet so many issues remain to 
reveal and so many other questions have arisen. The main conclusion taken from this study is 
that ATXN3L1 is a transcriptionally-active retrogene under selective constraints supporting its 
functional relevance. Even so, further studies need be done to confirm the presence of 
endogenous protein in vivo, in tissues where mRNA expression has been detected by us. Thus, 
we will design a specific anti-ATXN3L1 antibody to detect human endogenous ATXN3L1. After 
having confirmed the specificity of anti-ATXN3L1, the expression levels of ATXN3L1 will be 
assessed in human protein extracts, by Western blot, and in tissue sections by 
immunohistochemistry. Next, to better understand the functional diversification of ATXN3L1,  we 
expect to have mammalian cell lines stably expressing ATXN3L1, which will allow us to 
determine ATXN3L1 subcellular location, by fluorescence, and to test its binding to ATXN3, as 
well as to the transcriptional coactivators and DNA repair proteins that interact with the parental 
ATXN3. 
Further studies can be made, also, to confirm if the small ATXN3L2 ORFs are transcribed or 
not, since it may have functional relevance by regulating the expression of the parental gene, as 
demonstrated for other transcripts originated from retrogenes. To detect mRNA expression of 
ATXN3L2, RT-PCR will be performed with allele-specific primers in cDNAs of 20 different 
normal human tissues (the same approach we used for ATXN3L1). To unequivocally 
discriminate this transcript from the homologous, primers will be designed to amplify 
concatenated regions corresponding to ATXN3 exons, in gene-specific nucleotides with highly 
conserved sites across species within orthologues. 
We can also increase the reliability of our phylogenetic analysis of selection including more 
species sequences. Most of the species analyzed in this work were successfully sequenced for 
ATXN3L1 and ATXN3L2, lacking the ATXN3 sequence. Specific primers must be design to 
amplify the ATXN3 gene of species assessed for the other paralogues. Finally, a higher and 
widest sampling can also help us to get closer to more reliable nucleotide diversity.  
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Samples Sex Samples Sex 
Chimpanzee 1 male Japanese macaque 3 male 
Chimpanzee 2 female Japanese macaque 4 male 
Chimpanzee 3 male Japanese macaque 5 female 
Gorilla 1 female Japanese macaque 6 male 
Gorilla 2 male Japanese macaque 7 female 
Gorilla 3 male Japanese macaque 8 female 
Gorilla 4 female Japanese macaque 9 female 
Orangutan 1 male Japanese macaque 10 female 
Orangutan 2 male Japanese macaque 11 female 
Orangutan 3 male Japanese macaque 12 male 
Gibbon female Japanese macaque 13 female 
Baboon 1 female Japanese macaque 14 female 
Baboon 2 female Japanese macaque 15 male 
Baboon 3 male Cynomolgous monkey 1 male 
Rhesus monkey 1 male Cynomolgous monkey 2 female 
Rhesus monkey 2 male Cynomolgous monkey 3 female 
Rhesus monkey 3 male Cynomolgous monkey 4 male 
Rhesus monkey 4 male African green monkey female 
Rhesus monkey 5 female Owl monkey female 
Rhesus monkey 6 female Marmoset 1 female 
Rhesus monkey 7 female Marmoset 2 male 
Japanese macaque 1 female Marmoset 3 female 
Japanese macaque 2 female Cotton-top tamarin  female 
Table A1: Gender of all samples analyzed in this work. (The                                    
gender was determined by us (see Results section, “Sex determination”)) 
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Species  Common name 
Homo sapiens  Human 
Pan troglodytes  Chimpanzee 
Pan paniscus  Pigmy chimpanzee 
Gorilla gorilla  Gorilla 
Pongo abelii   Sumatran orangutan 
Pygmaeus pongus  Orangutan 
Nomascus leucogenys  Northern white-cheeked gibbon 
Hylobates   Gibbon 
Papio anubis   Olive Baboon 
Papio hamadryas  Baboon 
Macaca mulatta  Rhesus monkey 
Macaca fuscata  Japanese macaque 
Macaca fascicularis  Cynomolgous monkey 
Cercopithecus aethiops  African green monkey 
Aotus trivirgatus  Owl monkey 
Saimiri boliviensis   Squirrel monkey 
Callithrix jacchus  Marmoset 
Saguinus oedipus  Cotton-top tamarin 
Tarsius syrichta  Tarsier 
Otolemur garnettii  Bushbaby 
   
 
 
 
 
 
 
Table A2: Common name of all the species analyzed in this work. 
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Models Parameters 
 
run mode model Nsites ncatG ω ωinitial 
Branch models       
one-ratio 0 0 0 2 0 1.6 
two-ratio 0 2 0 2 0 1.6 
free-ratio 0 1 0 2 0 1.6 
Site models 
      
M1 0 0 1 2 0 1.6 
M2 0 0 2 2 0 1.6 
M7 0 0 7 2 0 1.6 
M8 0 0 8 2 0 1.6 
Branch-site models 
      H0 0 2 2 4 1 1 
H1.0 0 2 2 4 0 0 
H1.1 0 2 2 4 0 1 
H1.2 0 2 2 4 0 2 
H1.4 0 2 2 4 0 4 
H1.5 0 2 2 4 0 5 
 
 
 
 
 
 
 
 
 
Table A3: Parameters used in codeml for phylogenetic analysis of selection. 
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Table A4: Nucleotide diversity found in ATXN3L1. Absolute frequencies, MAF (Minor Allele Frequency) and amino acid 
change were not determined for P. anubis, M. fuscata and M. fascicularis due to heterozygous positions found in males.  
A – adenine; C – cytosine; G – guanine; T – timine; MAF - maximum allele frequency; V - Valine; T – Threonine; E - 
Glutamic acid; R – Arginine; K – Lysine; N – Asparagine; M- Methionine; Y – Tyrosine; D - Aspartic acid; G – Glycine; L - 
Leucine  
 
Species Variation ID
Base 
position
Number of 
chromosomes 
analyzed 
Base 
change
Absolute 
frequencies 
MAF
Amino 
acid 
change
c.295C>T 295 C/T 1/4 0.8
c.296C>A 296 C/A 1/4 0.8
c.356A>G 356 A/G 1/4 0.8 H/R
c.363C>T 363 C/T 1/4 0.8 F/F
c.368C>T 368 C/T 1/4 0.8 I/T
c.397C>T 397 C/T 1/4 0.8 L/L
c.409C>T 409 C/T 1/4 0.8 L/L
c.420A>G 420 A/G 1/4 0.8 P/P
c.443C>T 443 C/T 1/4 0.8 L/P
c.460C>T 460 C/T 1/4 0.8 R/stop
c.664A>G 664 4 A/G 3/1 0.75 G/G
c.37C>T 37 C/T 5/2 0.71 L/L
c.307A>G 307 A/G 5/2 0.71 S/G
c.378C>T 378 C/T 6/1 0.86 F/F
c.414A>G 414 A/G 3/4 0.57 A/A
c.417T>G 417 T/G 3/4 0.57 G/G
c.427A>G 427 A/G 3/4 0.57 I/V
c.435C>T 435 C/T 2/5 0.71 D/D
c.472C>G 472 C/G 2/5 0.71 E/Q
c.587C>T 587 C/T 2/5 0.71 L/S
c.606C>T 606 C/T 2/5 0.71 H/H
c.636A>G 636 A/G 5/2 0.71 V/V
c.678C>G 678 C/G 2/5 0.71 E/D
c.694A>G 694 A/G 2/5 0.71 A/T
c.737A>C 737 A/C 2/5 0.71
c.738C>T 738 C/T 2/5 0.71
c.777C>T 777 C/T 5/2 0.71 S/S
c.852A>G 852 A/G 5/2 0.71 E/E
c.865A>C 865 A/C 5/2 0.71 K/Q
c.887A>T 887 A/T 5/2 0.71 Q/L
C.915C>T 915 C/T 5/2 0.71 G/G
c.916C>T 916 C/T 5/2 0.71 H/Y
c.928A>C 928 A/C 2/5 0.71 L/I
c.934A>G 934 A/G 1/6 0.86 E/K
c.962C>T 962 C/T 1/6 0.86 T/I
c.972C>T 972 C/T 2/5 0.71 D/D
c.1003C>T 1003 C/T 2/5 0.71 Stop/Q
c.435C>T 435 C/T 1/2 0.67 D/D
c.989A>G 989 A/G 1/2 0.67 S/N
c.1045C>T 1045 C/T 1/2 0.67 L/L
c.280C>T 280 C/T
c.319A>G 319 A/G
c.987A>T 987 A/T
c.1006A>G 1006 A/G
c.1007C>T 1007 C/T
c.1011C>T 1011 C/T
M. mulatta c.174 C>T 174 11 C/T 7/4 0.64 Y/Y
c.561T>G 561 T/G
c.743A>G 743 A/G
c.923A>C 923 A/C
c.995C>T 995 C/T
c.801A/C 801 A/C
c.975C/T 975 C/T
C. jacchus c.930A>T 930 6 A/T 3/3 0,5 D/E
Y/P
5
P. troglodytes
7
M. fuscata
M. fascicularis
A/D
P. anubis
5
6
P. abelii
G. gorilla
3
25
6
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Table A5: Nucleotide diversity found in ATXN3L2. 
Species Variation ID
Base 
position
Number of 
chromosomes 
analyzed 
Base 
change
Absolute 
frequencies 
MAF
c.434G>T 434 G/T 5/2 0.71
c.577C>T 577 C/T 5/2 0.71
c.1021C>G 1021 C/G 5/2 0.71
c.56A>G 56 A/G 7/2 0.78
c.65A>T 65 A/T 1/8 0.89
c.122A>T 122 A/T 2/7 0.78
c.185A>T 185 A/T 2/7 0.78
c.190A>C 190 A/C 7/2 0.78
c.195C>G 195 C/G 2/7 0.78
c.198C>T 198 C/T 2/7 0.78
c.218T>G 218 T/G 6/3 0.67
c.223.1T 223 insT 4/5 0.56
c.224C>G 224 C/G 8/1 0.89
c.225C>G 225 C/G 8/1 0.89
c.225.4T 225 ins4T 1/8 0.89
c.225.4T.1G.1C.4T 225 ins4TGC4T 1/8 0.89
c.302A>G 302 A/G 2/7 0.78
c.310A>G 310 A/G 7/2 0.78
c.331A>G 331 A/G 7/2 0.78
c.344C>T 344 C/T 2/7 0.78
c.362A>G 362 A/G 6/3 0.67
c.366C>T 366 C/T 4/5 0.56
c.371A>T 371 A/T 7/2 0.78
c.434T-del 434 delT 2/7 0.78
c.530C>T 530 C/T 7/2 0.78
c.574C>T 574 C/T 7/2 0.78
c.575C>T 575 C/T 7/2 0.78
c.581A>G 581 A/G 7/2 0.78
c.592C>T 592 C/T 7/2 0.78
c.647A>G 647 A/G 7/2 0.78
c.651C>T 651 C/T 8/1 0.89
c.654A>G 654 A/G 7/2 0.78
c.668A>G 668 A/G 2/7 0.78
c.669A>G 669 A/G 2/7 0.78
c.679A>T 679 A/T 7/2 0.78
c.684C>T 684 C/T 1/8 0.89
c.694C>G 694 C/G 7/2 0.78
c.722A>G 722 A/G 2/7 0.78
c.727A>G 727 A/G 1/8 0.89
c.779A>G 779 A/G 2/7 0.78
c.862A>G 862 A/G 2/7 0.78
c.875A>G 875 A/G 7/2 0.78
c.983A>G 983 A/G 2/7 0.78
c.1056A>T 1056 A/T 7/2 0.78
c.231_236GCTTTT-del 231_236 delGCTTTT 2/3 0.6
c.658C>T 658 C/T 4/1 0.8
c.691C>T 691 C/T 4/1 0.8
c.734A>G 734 A/G 1/4 0.8
5P. abelii
P. troglodytes 7
G. gorilla 9
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A – adenine; C – cytosine; G – guanine; T – timine; MAF - maximum allele frequency. 
 
Table A5 (continuation): Nucleotide diversity found in ATXN3L2.  
c.49_101indel 49_101 indel 1/6 0.86
c.102T>G 102 T/G 4/3 0.57
c.373T>G 373 T/G 6/1 0.86
c.556T>G 556 T/G 6/1 0.86
c.987A>G 987 A/G 1/6 0.86
c.1049T>G 1049 T/G 2/5 0.71
c.29_31AAG-del 28_31 delAAG 1/14 0.93
c.36 A>G 36 A/G 1/14 0.93
c.73A>G 73 A/G 7/8 0.53
c.261C>T 261 C/T 1/14 0.93
c.267A>G 267 A/G 14/1 0.93
c.341A>C 341 A/C 10/5 0.67
c.420A>G 420 A/G 1/14 0.93
c.680A>G 680 A/G 1/14 0.93
c.740C>G 740 C/G 14/1 0.93
c.795A>G 795 A/G 14/1 0.93
c.864A>G 864 A/G 10/5 0.67
c.1015C>T 1015 C/T 6/9 0.6
c.575A>G 575 A/G 25/5 0.83
c.579A>G 579 A/G 4/26 0.87
c.581C>T 581 C/T 29/1 0.97
c.73A>G 73 A/G 4/4 0.63
c.134A>G 134 A/G 3/5 0.63
c.180A>C 180 A/C 1/7 0.88
c.341A>C 341 A/C 4/4 0.63
c.471C>T 471 C/T 3/5 0.63
c.495A>G 495 A/G 5/3 0.63
c.507A>G 507 A/G 4/4 0.63
c.549A>G 549 A/G 5/3 0.63
c.627T>G 627 T/G 3/5 0.63
c.821C>T 821 C/T 4/4 0.63
c.864A>G 864 A/G 4/4 0.63
c.1048A>G 1048 A/G 1/7 0.88
M. fuscata
M. fascicularis
15
30
8
M. mulatta
P. anubis 7
